
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23382933</article-id><article-id pub-id-type="pmc">3559828</article-id><article-id pub-id-type="publisher-id">PONE-D-12-30723</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0054648</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Neurochemistry</subject><subj-group><subject>Neurochemicals</subject><subj-group><subject>Neuropeptides</subject></subj-group></subj-group></subj-group><subj-group><subject>Proteins</subject><subj-group><subject>Nicotinic Acetylcholine Receptors</subject><subject>Protein Structure</subject></subj-group></subj-group><subj-group><subject>Chemical Biology</subject><subject>Drug Discovery</subject></subj-group></subj-group><subj-group><subject>Genetics</subject><subj-group><subject>Cloning</subject><subject>Gene Function</subject></subj-group></subj-group><subj-group><subject>Proteomics</subject><subj-group><subject>Synthetic Peptide</subject></subj-group></subj-group><subj-group><subject>Toxicology</subject><subj-group><subject>Neurotoxicology</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Chemistry</subject><subj-group><subject>Applied Chemistry</subject><subj-group><subject>Chemical Properties</subject><subj-group><subject>Nuclear Magnetic Resonance</subject></subj-group></subj-group></subj-group><subj-group><subject>Physical Chemistry</subject><subj-group><subject>Chemical Properties</subject><subj-group><subject>Nuclear Magnetic Resonance</subject></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>A Novel Inhibitor of &#x003b1;9&#x003b1;10 Nicotinic Acetylcholine Receptors from <italic>Conus vexillum</italic> Delineates a New Conotoxin Superfamily</article-title><alt-title alt-title-type="running-head">Novel &#x003b1;B-Conotoxin VxXXIVA</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Luo</surname><given-names>Sulan</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Christensen</surname><given-names>Sean</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Zhangsun</surname><given-names>Dongting</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Yong</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Hu</surname><given-names>Yuanyan</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Zhu</surname><given-names>Xiaopeng</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Chhabra</surname><given-names>Sandeep</given-names></name><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Norton</surname><given-names>Raymond S.</given-names></name><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>McIntosh</surname><given-names>J. Michael</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>
<addr-line>Key Laboratory of Tropical Biological Resources, Ministry of Education, Key Lab for Marine Drug of Haikou, Hainan University, Haikou Hainan, China</addr-line>
</aff><aff id="aff2">
<label>2</label>
<addr-line>Departments of Biology and Psychiatry, University of Utah, Salt Lake City, Utah, United States of America</addr-line>
</aff><aff id="aff3">
<label>3</label>
<addr-line>Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Australia</addr-line>
</aff><contrib-group><contrib contrib-type="editor"><name><surname>Motta</surname><given-names>Andrea</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">
<addr-line>National Research Council of Italy, Italy</addr-line>
</aff><author-notes><corresp id="cor1">* E-mail: <email>luosulan2003@163.com</email></corresp><fn fn-type="COI-statement"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="con"><p>Conceived and designed the experiments: SL JMM. Performed the experiments: SL S. Christensen DZ YW YH XZ S. Chhabra RSN JMM. Analyzed the data: SL S. Christensen S. Chhabra RSN JMM. Contributed reagents/materials/analysis tools: S. Christensen YW. Wrote the paper: SL RSN JMM.</p></fn></author-notes><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>30</day><month>1</month><year>2013</year></pub-date><volume>8</volume><issue>1</issue><elocation-id>e54648</elocation-id><history><date date-type="received"><day>9</day><month>10</month><year>2012</year></date><date date-type="accepted"><day>13</day><month>12</month><year>2012</year></date></history><permissions><copyright-statement>&#x000a9; 2013 Luo et al</copyright-statement><copyright-year>2013</copyright-year><copyright-holder>Luo et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><abstract><p>Conotoxins (CTxs) selectively target a range of ion channels and receptors, making them widely used tools for probing nervous system function. Conotoxins have been previously grouped into superfamilies according to signal sequence and into families based on their cysteine framework and biological target. Here we describe the cloning and characterization of a new conotoxin, from <italic>Conus vexillum</italic>, named &#x003b1;B-conotoxin VxXXIVA. The peptide does not belong to any previously described conotoxin superfamily and its arrangement of Cys residues is unique among conopeptides. Moreover, in contrast to previously characterized conopeptide toxins, which are expressed initially as prepropeptide precursors with a signal sequence, a &#x02018;&#x02018;pro&#x02019;&#x02019; region, and the toxin-encoding region, the precursor sequence of &#x003b1;B-VxXXIVA lacks a &#x02018;&#x02018;pro&#x02019;&#x02019; region. The predicted 40-residue mature peptide, which contains four Cys, was synthesized in each of the three possible disulfide arrangements. Investigation of the mechanism of action of &#x003b1;B-VxXXIVA revealed that the peptide is a nicotinic acetylcholine receptor (nAChR) antagonist with greatest potency against the &#x003b1;9&#x003b1;10 subtype. <sup>1</sup>H nuclear magnetic resonance (NMR) spectra indicated that all three &#x003b1;B-VxXXIVA isomers were poorly structured in aqueous solution. This was consistent with circular dichroism (CD) results which showed that the peptides were unstructured in buffer, but adopted partially helical conformations in aqueous trifluoroethanol (TFE) solution. The &#x003b1;9&#x003b1;10 nAChR is an important target for the development of analgesics and cancer chemotherapeutics, and &#x003b1;B-VxXXIVA represents a novel ligand with which to probe the structure and function of this protein.</p></abstract><funding-group><funding-statement>This work was supported by Program for Changjiang Scholars and Innovative Research Team in University(PCSIRT, IRT1123), State High-Tech Research and Development Project (863) of the Ministry of Science and Technology of China (2012AA021706), International Science &#x00026; Technology Cooperation Program of China (2011DFR31210), and National Natural Science Foundation of China (No. 81160503). A preliminary account of some of this work was presented in the patent literature (Luo,S, et al. CN(201210117928.9)-A 2012). Support also was received from National Institute of Health Grants GM 48677 and GM103801 and RSN acknowledges fellowship support from the Australian National Health and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="10"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Nicotinic acetylcholine receptors (nAChRs) are pentameric ligand-gated ion channels used throughout the animal kingdom for neurotransmission. These receptors are assembled from &#x003b1;,&#x003b2;,&#x003b3;,&#x003b4; and/or &#x003b5; subunits to form multiple receptor subtypes with distinct pharmacological properties <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>. Elucidation of the precise structure and function of various nAChRs is challenging owing to the scarcity of ligands selective for specific receptor subtypes. In an effort to address this, we have systematically examined components of the venoms of carnivorous cone snails for selective nAChR-targeted ligands.</p><p>Molluscs of the genus <italic>Conus</italic> are comprised of &#x0003e;700 species. These marine snails hunt primarily polychaete worms, molluscs or fish. Each cone species produces a cocktail of &#x0003e;100 different compounds that enables prey capture. Despite extensive work, the vast majority of these compounds remains uncharacterized. Conopeptides are produced in the venom duct of <italic>Conus</italic> and used offensively to immobilize prey. Their potency and selectivity for various ion channels and receptors have made them excellent pharmacological probes and drug leads <xref rid="pone.0054648-Espiritu1" ref-type="bibr">[2]</xref>&#x02013;<xref rid="pone.0054648-Norton1" ref-type="bibr">[3]</xref>. The term conotoxin is used to describe the subset of <italic>Conus</italic> peptides that are rich in Cys residues. Conotoxins are synthesized initially as precursor proteins that are subsequently processed into the mature toxin. Previously characterized <italic>Conus</italic> peptides have been grouped into gene superfamilies based on similarities in their precursor signal sequences <xref rid="pone.0054648-Daly1" ref-type="bibr">[4]</xref>. Within each superfamily, the toxins are grouped according to cysteine frameworks that influence their final three-dimensional structure. The toxins are also grouped according to receptor or ion channel target into pharmacological families. Within a given family of conotoxins there is, characteristically, hypervariation in non-Cys residues, which is believed to enable selective action on a given target subtype. Post-translational modification or chemical synthetic modification provides further diversity <xref rid="pone.0054648-Olivera1" ref-type="bibr">[5]</xref>&#x02013;<xref rid="pone.0054648-Armishaw1" ref-type="bibr">[6]</xref>.</p><p>Toxins characterized to date can be classified into one of 17 superfamilies (see <xref ref-type="table" rid="pone-0054648-t001">Table 1</xref>) <xref rid="pone.0054648-Kaas1" ref-type="bibr">[7]</xref>&#x02013;<xref rid="pone.0054648-Ye1" ref-type="bibr">[8]</xref>. The current study characterizes a new conotoxin, from the worm-hunting <italic>Conus vexillum</italic>, with a unique Cys framework. As the precursor sequence does not align with any of the previously-reported gene superfamilies, this peptide represents a first-in-class compound (see (<xref ref-type="supplementary-material" rid="pone.0054648.s006">Table S1</xref>)). Total chemical synthesis was carried out to enable pharmacological and structural characterization of this novel toxin. The peptide acts as an antagonist of nicotinic acetylcholine receptors, with greatest potency at the &#x003b1;9&#x003b1;10 nAChR, a subtype expressed in a variety of tissues ranging from immune cells to sperm <xref rid="pone.0054648-Plazas1" ref-type="bibr">[9]</xref>&#x02013;<xref rid="pone.0054648-McIntosh1" ref-type="bibr">[10]</xref>.</p><table-wrap id="pone-0054648-t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0054648.t001</object-id><label>Table 1</label><caption><title>Protein precursor sequences of <italic>Conus</italic> gene superfamilies <xref rid="pone.0054648-Luo1" ref-type="bibr">[46]</xref>&#x02013;<xref rid="pone.0054648-Yuan2" ref-type="bibr">[61]</xref>.</title></caption><alternatives><graphic id="pone-0054648-t001-1" xlink:href="pone.0054648.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Super-family</td><td align="left" rowspan="1" colspan="1">Peptide</td><td align="left" rowspan="1" colspan="1">Precursor Sequence (Signal, <italic>N-terminal pro-regions,</italic> &#x02193;<underline>Mature peptide</underline> and &#x02193;<italic>C-terminal pro-regions</italic>)</td><td align="left" rowspan="1" colspan="1">Reference</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">B</td><td align="left" rowspan="1" colspan="1">&#x003b1;B-VxXXIVA</td><td align="left" rowspan="1" colspan="1">METLTLLWRASSSCLLVVLSHSLLRLLG&#x02193;<underline>VR<bold>C</bold>LEKSGAQPNKLFRPP<bold>CC</bold>QKGPSFARHSR<bold>C</bold>VYYTQSRE</underline>
</td><td align="left" rowspan="1" colspan="1">This Study</td></tr><tr><td align="left" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">&#x003b1;-LtIA</td><td align="left" rowspan="1" colspan="1">MGMRMMFIMFMLVVLATTVVTFTS<italic>DRALDAMNAAASNKA</italic>
<italic>SRLIALAVR</italic>&#x02193;<underline>G<bold>CC</bold>ARAA<bold>C</bold>AGIHQEL<bold>C</bold></underline>&#x02193;GGGR</td><td align="left" rowspan="1" colspan="1">46,47,48</td></tr><tr><td align="left" rowspan="1" colspan="1">D</td><td align="left" rowspan="1" colspan="1">&#x003b1;D-VxXXB</td><td align="left" rowspan="1" colspan="1">MPKLAVVLLVLLILPLSYFDAAGG<italic>QAVQGDWRGNRLARD</italic>
<italic>LQRGGR</italic>&#x02193;<underline>DDESE<bold>C</bold>IINTRDSPWGR<bold>CC</bold>RTRM<bold>C</bold>GSM<bold>CC</bold>PRNG<bold>C</bold>T<bold>C</bold>VYHWRRGHG<bold>C</bold>S<bold>C</bold>PG</underline>
</td><td align="left" rowspan="1" colspan="1">49,50</td></tr><tr><td align="left" rowspan="1" colspan="1">I<sub>1</sub>
</td><td align="left" rowspan="1" colspan="1">ArXIA</td><td align="left" rowspan="1" colspan="1">MKLCATFLLVLVTLPLVTG<italic>EKSSERSLSGAILRGVR</italic>&#x02193;<underline>RT<bold>C</bold>S</underline>
<underline>RRGHR<bold>C</bold>IRDSQ<bold>CC</bold>GGM<bold>CC</bold>QGNR<bold>C</bold>FVAIRR<bold>C</bold>FHLPF</underline>
</td><td align="left" rowspan="1" colspan="1">51</td></tr><tr><td align="left" rowspan="1" colspan="1">I<sub>2</sub>
</td><td align="left" rowspan="1" colspan="1">BeTX</td><td align="left" rowspan="1" colspan="1">MMFRVTSVGCLLLVIVFLNLVVPTSA&#x02193;<bold><underline>C</underline></bold>
<underline>RAEGTY<bold>C</bold>ENDS</underline>
<underline>Q<bold>CC</bold>LNE<bold>CC</bold>WGG<bold>C</bold>GHP<bold>C</bold>RHP</underline>&#x02193;<italic>GKRSKLQEFFRQR</italic>
</td><td align="left" rowspan="1" colspan="1">52</td></tr><tr><td align="left" rowspan="1" colspan="1">I<sub>3</sub>
</td><td align="left" rowspan="1" colspan="1">Ca11.3</td><td align="left" rowspan="1" colspan="1">MKLVLAIVVILMLLSLSTGA<italic>EMSDNHASRSATALRDRLLSP</italic>
<italic>K</italic>&#x02193;<underline>ASI<bold>C</bold>YGTGGR<bold>C</bold>TKDKH<bold>CC</bold>GWL<bold>CC</bold>GGPSVG<bold>C</bold>VVSVAP<bold>C</bold>K</underline>
</td><td align="left" rowspan="1" colspan="1">53</td></tr><tr><td align="left" rowspan="1" colspan="1">J</td><td align="left" rowspan="1" colspan="1">Fe14.1</td><td align="left" rowspan="1" colspan="1">MPSVRSVTCCCLLWMMLSVQLVTPGSPGTAQLSGHRTAR&#x02193;<underline>SPGSTI<bold>C</bold>KMA<bold>C</bold>RTGNGHKYPFCNCR</underline>&#x02193;GKRDVVSSSMAV</td><td align="left" rowspan="1" colspan="1">31</td></tr><tr><td align="left" rowspan="1" colspan="1">K</td><td align="left" rowspan="1" colspan="1">im23a</td><td align="left" rowspan="1" colspan="1">MIMRMTLTLFVLVVMTAASASG<italic>DALTEAKR</italic>
<underline>IPYCGQTGA</underline>
<underline>ECYSWCIKQDLSKDWCCDFVKDIRMNPPADKCP</underline>
</td><td align="left" rowspan="1" colspan="1">8</td></tr><tr><td align="left" rowspan="1" colspan="1">L</td><td align="left" rowspan="1" colspan="1">C14.1a</td><td align="left" rowspan="1" colspan="1">MNVTVMFLVLLLLTMPLTDG<italic>FNIRATNGGELFGPVQRDAG</italic>
<italic>NVLDHGFQRRR</italic>&#x02193;<underline>D<bold>C</bold>PPW<bold>C</bold>PTSH<bold>C</bold>NAGT<bold>C</bold></underline>
</td><td align="left" rowspan="1" colspan="1">54</td></tr><tr><td align="left" rowspan="1" colspan="1">M</td><td align="left" rowspan="1" colspan="1">&#x003c8;-PrIIIE</td><td align="left" rowspan="1" colspan="1">MSKLGVLLTICLLLFPITA<italic>LPVDGDQPADRPVERMQDNISS</italic>
<italic>EQHPFFEKR</italic>&#x02193;<underline>AAR<bold>CC</bold>TYHGS<bold>C</bold>LKEK<bold>C</bold>RRKY<bold>CC</bold></underline>&#x02193;GR</td><td align="left" rowspan="1" colspan="1">55</td></tr><tr><td align="left" rowspan="1" colspan="1">O<sub>1</sub>
</td><td align="left" rowspan="1" colspan="1">SO3</td><td align="left" rowspan="1" colspan="1">MKLTCMVIVAVLLLTACQLITA<italic>DDSRGTQKHRTLRSKTKL</italic>
<italic>SMSTR</italic>&#x02193;<bold><underline>C</underline></bold>
<underline>KAAGKP<bold>C</bold>SRIAYN<bold>CC</bold>TGS<bold>C</bold>RSGK<bold>C</bold></underline>&#x02193;G</td><td align="left" rowspan="1" colspan="1">56</td></tr><tr><td align="left" rowspan="1" colspan="1">O<sub>2</sub>
</td><td align="left" rowspan="1" colspan="1">BeB54</td><td align="left" rowspan="1" colspan="1">MEKLTILLLVAAVLMSTQALI<italic>QSDGEKRQQAKINFLS.R</italic>&#x02193;<underline>K</underline>
<underline>STAESWWEGE<bold>C</bold>KGWSVY<bold>C</bold>SWDWE<bold>CC</bold>SGE<bold>C</bold>TRYY<bold>C</bold>ELW</underline>
</td><td align="left" rowspan="1" colspan="1">17</td></tr><tr><td align="left" rowspan="1" colspan="1">O<sub>3</sub>
</td><td align="left" rowspan="1" colspan="1">CaFr179</td><td align="left" rowspan="1" colspan="1">MSGLGIMVLTLLLLVFMEA<italic>SHQDAGEKQATQRDAINVRR</italic>
<italic>RRSLARR</italic>&#x02193;<underline>TVTEE<bold>C</bold>EED<bold>C</bold>EDEEKH<bold>CC</bold>NTNNGPS<bold>C</bold>ARL<bold>C</bold>F</underline>&#x02193;G</td><td align="left" rowspan="1" colspan="1">17</td></tr><tr><td align="left" rowspan="1" colspan="1">P</td><td align="left" rowspan="1" colspan="1">GmIXA</td><td align="left" rowspan="1" colspan="1">MHLSLARSAVLMLLLLFALGNFVVVQS<italic>GLITRDVDNGQL</italic>
<italic>TDNRRNLQTEWNPLSLFMSRR</italic>&#x02193;<underline>S<bold>C</bold>NNS<bold>C</bold>QSHSD<bold>C</bold>ASH<bold>C</bold>I<bold>C</bold>TFRG <bold>C</bold>GAVN</underline>&#x02193;G</td><td align="left" rowspan="1" colspan="1">57</td></tr><tr><td align="left" rowspan="1" colspan="1">S</td><td align="left" rowspan="1" colspan="1">&#x003b1;S-GVIIIA</td><td align="left" rowspan="1" colspan="1">MMSKMGAMFVLLLLFTLAS<italic>SLQEGDVQARKTRLKSDFYR</italic>
<italic>ALARDDR</italic>&#x02193;<underline>G<bold>C</bold>TRT<bold>C</bold>GGPK<bold>C</bold>TGT<bold>C</bold>T<bold>C</bold>TNSSK<bold>C</bold>G<bold>C</bold>RYNVHPSGWG<bold>C</bold>G<bold>C</bold>A<bold>C</bold>S</underline>&#x02193;G</td><td align="left" rowspan="1" colspan="1">58</td></tr><tr><td align="left" rowspan="1" colspan="1">T</td><td align="left" rowspan="1" colspan="1">VcVB</td><td align="left" rowspan="1" colspan="1">VILLLLIASAPSVDA<italic>QPKTKDDVPLAPLHDNAKSALQHLNQ</italic>
<italic>R</italic>&#x02193;<bold><underline>CC</underline></bold>
<underline>QTFYW<bold>CC</bold>GQ</underline>&#x02193;GK</td><td align="left" rowspan="1" colspan="1">59</td></tr><tr><td align="left" rowspan="1" colspan="1">V</td><td align="left" rowspan="1" colspan="1">ViXVA</td><td align="left" rowspan="1" colspan="1">MMPVILLLLLSLAIRCADG<italic>KAVQGDSDPSASLLTGDKNHD</italic>
<italic>LPVKR</italic>&#x02193;<underline>D<bold>C</bold>TT<bold>C</bold>AGEE<bold>CC</bold>GR<bold>C</bold>T<bold>C</bold>PWGDN<bold>C</bold>S<bold>C</bold>IEW</underline>&#x02193;GK</td><td align="left" rowspan="1" colspan="1">60</td></tr><tr><td align="left" rowspan="1" colspan="1">Y</td><td align="left" rowspan="1" colspan="1">CaXVIIA</td><td align="left" rowspan="1" colspan="1">MQKATVLLLALLLLLPLSTA<italic>QDAEGSQEDAAQREVDIATR</italic>&#x02193;<bold><underline>C</underline></bold>
<underline>GGTGDS<bold>C</bold>NEPAGEL<bold>CC</bold>RRLK<bold>C</bold>VNSR<bold>CC</bold>PTTDG<bold>C</bold></underline>
</td><td align="left" rowspan="1" colspan="1">61</td></tr></tbody></table></alternatives></table-wrap></sec><sec sec-type="materials|methods" id="s2"><title>Materials and Methods</title><sec id="s2a"><title>Ethics Statement</title><p>No specific permits were required for the described field studies. No specific permissions were required for Tanmen Qionghai, Hainan Province, China, which is not privately-owned or protected in any way. The field studies did not involve endangered or protected species.</p></sec><sec id="s2b"><title>Materials</title><p>Specimens of <italic>Conus vexillum</italic> were collected from the South China Sea off Tanmen Qionghai, Hainan Province, China. Venom ducts were frozen and stored at &#x02212;80&#x000b0;C. Creator SMART cDNA Library Construction Kit was from CLONTECH Laboratories, Inc. Acetylcholine chloride, atropine, and bovine serum albumin (BSA) were from Sigma. The reverse-phase HPLC analytical Vydac C18 column (5 &#x000b5;m, 4.6 mm&#x000d7;250 mm) and preparative C18 Vydac column (10 &#x000b5;m, 22 mm&#x000d7;250 mm) were from Shenyue. Reagents for peptide synthesis were from GL Biochem. Acetonitrile was from Fisher. Trifluoroacetic acid (TFA) was from Tedia. All other chemicals used were of analytical grade. Clones of rat &#x003b1;2&#x02013;&#x003b1;7 and &#x003b2;2&#x02013;&#x003b2;4, as well as mouse muscle &#x003b1;1&#x003b2;1&#x003b4;&#x003b5; cDNAs were kindly provided by S. Heinemann (Salk Institute, San Diego, CA). Clones for &#x003b1;9 and &#x003b1;10 were generously provided by A.B. Elgoyen (Instituto de Investigaciones en Ingenier&#x000ed;a Gen&#x000e9;tica y Biolog&#x000ed;a Molecular, Buenos Aires, Argentina). Clones of &#x003b2;2 and &#x003b2;3 subunits in the high expressing pGEMHE vector were kindly provided by C.W. Luetje (University of Miami, Miami, FL).</p></sec><sec id="s2c"><title>cDNA Sequencing</title><p>Total RNA was extracted from individual ducts and purified as described previously <xref rid="pone.0054648-Quan1" ref-type="bibr">[11]</xref>. Venom duct cDNA library construction followed the kit manufacturer&#x02019;s suggested protocol. Briefly, the first-strand cDNA was synthesized with the SMART IV Oligonucleotide and transcriptase. Full-length, double-stranded (ds) cDNA (SMART cDNA) was generated by long-distance PCR. SMART cDNA was ligated into the Sfi I predigested pDNR-LIB vector. The signal and mature peptide sequences of the conotoxin precursors were predicted using online ProP 1.0 Server <xref rid="pone.0054648-Duckert1" ref-type="bibr">[12]</xref>.</p></sec><sec id="s2d"><title>Peptide Synthesis</title><p>The linear peptide was assembled by solid-phase methodology on an ABI 433A peptide synthesizer using FastMoc (N-(9-fluorenyl) methoxycarbonyl) chemistry and standard side-chain protection, except for cysteine residues. Cys residues of the three possible isomers were protected in pairs with either S-trityl on Cys3 and Cys19 (designated &#x003b1;B-VxXXIVA <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>, <xref rid="pone.0054648-Espiritu1" ref-type="bibr">[2]</xref>), Cys3 and Cys20 (designated &#x003b1;B-VxXXIVA <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>, <xref rid="pone.0054648-Norton1" ref-type="bibr">[3]</xref>), Cys19 and Cys20 (designated &#x003b1;B-VxXXIVA <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>, <xref rid="pone.0054648-Daly1" ref-type="bibr">[4]</xref>) or S-acetamidomethyl on Cys20 and Cys32, Cys19 and Cys32, Cys3 and Cys32, respectively. The peptides were removed from a solid support by treatment with reagent K (TFA / water / ethanedithiol / phenol / thioanisole; 90&#x02236; 5 : 2.5&#x02236; 7.5&#x02236; 5,v / v / v / v / v). The released peptide was precipitated and washed three times with cold ether. A two-step oxidation protocol was used to fold the peptides selectively, as described previously <xref rid="pone.0054648-Dowell1" ref-type="bibr">[13]</xref>. Briefly, the disulfide bridge between Cys3 and Cys19, Cys3 and Cys20, or Cys19 and Cys20, respectively, was closed by dripping the peptide into an equal volume of 20 mM potassium ferricyanide, 0.1 M Tris, pH 7.5. The solution was allowed to react for 45 min, and the monocyclic peptide was purified by reverse-phase HPLC. Simultaneous removal of the S-acetamidomethyl groups and closure of the disulfide bridge between Cys20 and Cys32, Cys19 and Cys32, or Cys3 and Cys32, respectively, was carried out by iodine oxidation as follows: the monocyclic peptide in HPLC eluent was dripped into an equal volume of iodine (10 mM) in H<sub>2</sub>O:TFA:acetonitrile (74&#x02236;2:24 by volume) and allowed to react for 10 min. The reaction was terminated by the addition of ascorbic acid, diluted 10-fold with 0.1% TFA, and the bicyclic peptide was purified by HPLC on a reversed-phase C18 Vydac column using a linear gradient of 20&#x02013;60% B60 in 40 min. Solvent B was 60% ACN, 0.092% TFA, and H<sub>2</sub>O; Solvent A 0.1% TFA in H<sub>2</sub>O. Peptide concentration was measured using absorbance at 280 nm, and calculated using the Beer-Lambert equation and a calculated molar extinction coefficient of 3040 cm<sup>&#x02212;1</sup> M<sup>&#x02212;1</sup>.</p></sec><sec id="s2e"><title>cRNA Preparation and Injection</title><p>Capped cRNA for the various subunits were made using the mMessage mMachine <italic>in vitro</italic> transcription kit (Ambion) following linearization of the plasmid. The cRNA was purified using the Qiagen RNeasy kit. The concentration of cRNA was determined by absorbance at 260 nm. Oocytes were injected within one day of harvesting and recordings were made 1&#x02013;4 days post-injection.</p></sec><sec id="s2f"><title>Voltage-clamp Recording</title><p>Oocytes were voltage-clamped and exposed to ACh and peptide as described previously <xref rid="pone.0054648-Cartier1" ref-type="bibr">[14]</xref>. Briefly, the oocyte chamber consisting of a cylindrical well (&#x0223c;30 &#x000b5;l in volume) was gravity perfused at a rate of &#x0223c;2 ml/min with ND96 buffer (96.0 mM NaCl, 2.0 mM KCl, 1.8 mM CaCl<sub>2</sub>, 1.0 mM MgCl<sub>2</sub>, 5 mM HEPES, pH 7.1&#x02013;7.5) containing 0.1 mg/ml BSA. The Ba<sup>++</sup>-ND96 had 1.8 mM BaCl<sub>2</sub> in place of CaCl<sub>2</sub>. The membrane potential of the oocytes was clamped at &#x02212;70 mV. The oocyte was subjected once a minute to a 1 s pulse of 100 &#x000b5;M ACh. In the case of the &#x003b1;9&#x003b1;10 and muscle &#x003b1;1&#x003b2;1&#x003b4;&#x003b5; subtypes, there is a 1 s pulse of 10 &#x000b5;M Ach, and for the &#x003b1;7 subtype a 200 &#x000b5;M ACh pulse. For toxin concentrations &#x02265;10 &#x000b5;M, once a stable baseline was achieved, either ND-96 alone or ND-96 containing conotoxin was applied manually for 5 min prior to the addition of the agonist. All recordings were done at room temperature (&#x0223c;22&#x000b0;C).</p></sec><sec id="s2g"><title>Data Analysis</title><p>The average of five control responses just preceding a test response was used to normalize the test response to obtain &#x0201c;% response.&#x0201d; Each data point of a dose-response curve represents the average &#x000b1; S.E. of at least three oocytes. The dose-response data were fit to the equation, % response&#x0200a;=&#x0200a;100/[1+ ([toxin]/IC50)?n<sub>H</sub>], where n<sub>H</sub> is the Hill coefficient, by non-linear regression analysis using GraphPad Prism (GraphPad Software).</p></sec><sec id="s2h"><title>NMR Spectroscopy</title><p>
<sup>1</sup>H NMR spectra were recorded on &#x003b1;B-VxXXIVA isomers at a concentration of &#x0223c; 350 &#x000b5;M in 20 mM phosphate/10% <sup>2</sup>H<sub>2</sub>O buffer at pH &#x0223c; 5.8. The 1D spectra were acquired on a Bruker Avance 600 MHz NMR spectrometer equipped with cryogenic probe fitted with a <italic>z</italic> axis gradient. The NMR spectra were collected at 5&#x000b0;C using the excitation sculpting pulse sequence <xref rid="pone.0054648-Hwang1" ref-type="bibr">[15]</xref>. Spectra were acquired over 4K data points with 64 scans and a <sup>1</sup>H spectral width of 14 ppm. All spectra were processed in TOPSPIN (version 3.0) and referenced to the water resonance.</p></sec><sec id="s2i"><title>Circular Dichroism Analysis</title><p>&#x003b1;B-VxXXIVA isomers were dissolved in 20 mM phosphate buffer (pH 5.9) and CD spectra were recorded on a Jasco-815 spectropolarimeter at a concentration of 43 &#x000b5;M at 20&#x000b0;C. Spectra were collected at 0.05 nm intervals over the wavelength range 260&#x02013;195 nm in a 10 mm pathlength cuvette. Three scans were collected and averaged for each peptide sample with scanning rate of 100 nm/min<sup>&#x02212;1</sup>. The spectra were then smoothed using a third-order polynomial function. In order to investigate the effect of trifluoroethanol (TFE) on the conformation, CD spectra for &#x003b1;B-VxXXIVA <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>, <xref rid="pone.0054648-Espiritu1" ref-type="bibr">[2]</xref> were also acquired following the addition of 10, 20, 50 and 87% TFE. The % &#x003b1;-helix and &#x003b2;-sheet content were calculated from the CD data using the CDPro program <xref rid="pone.0054648-Sreerama1" ref-type="bibr">[16]</xref>.</p></sec></sec><sec id="s3"><title>Results</title><sec id="s3a"><title>Discovery and Sequence Analysis of a cDNA of the Precursor of &#x003b1;B-VxXXIVA</title><p>In general, conotoxins are translated initially as prepropeptide precursors <xref rid="pone.0054648-Kaas1" ref-type="bibr">[7]</xref>, with proteolytic cleavage yielding the final product(s). Peptides in the same superfamily are characterized by highly conserved prepropeptide precursor sequences. This conservation has allowed direct identification of new peptides belonging to a particular superfamily by cDNA sequencing of family or superfamily genes <xref rid="pone.0054648-Zhangsun1" ref-type="bibr">[17]</xref>. However, a large fraction of conotoxins present in the <italic>Conus</italic> genus has yet to be sequenced and several additional families of toxins remain to be identified. Most of the cone snails investigated to date are fish- or mollusc-hunters. In an effort to discover novel conotoxin families, we examined the worm-hunting <italic>C. vexillum.</italic> Specimens were collected from the South China Sea and dissected venom ducts were used to construct a cDNA library. Approximately 50 clones from the cDNA library were chosen randomly for sequencing and inspected for previously unreported sequences. In the present study with <italic>C. vexillum</italic>, several members of the previously characterized &#x003b1;- and &#x003c9;- superfamilies were identified. In addition, however, an unusual precursor sequence was noted (<xref ref-type="fig" rid="pone-0054648-g001">Fig. 1</xref>, <xref ref-type="table" rid="pone-0054648-t001">Table 1</xref>, GenBank accession number JX297421). A sequence similarity search detected no homology with precursors of the known superfamilies of conotoxins <xref rid="pone.0054648-Kaas1" ref-type="bibr">[7]</xref> (<xref ref-type="supplementary-material" rid="pone.0054648.s006">Table S1</xref>). The sequence was analyzed with DNAstar software and online ProP 1.0 Server <xref rid="pone.0054648-Duckert1" ref-type="bibr">[12]</xref>, which indicated a 28-residue signal sequence followed by a previously unreported 40-residue mature toxin (<xref ref-type="table" rid="pone-0054648-t002">Table 2</xref> and see also <xref ref-type="supplementary-material" rid="pone.0054648.s007">Table S2</xref> for sequence alignment). For other conotoxins, the encoding cDNA has a characteristic three-region organization, including a signal sequence, a &#x02018;&#x02018;pro&#x02019;&#x02019; region, and the toxin-encoding region <xref rid="pone.0054648-Kaas1" ref-type="bibr">[7]</xref>, <xref rid="pone.0054648-Kaas2" ref-type="bibr">[18]</xref> The generation of the mature toxin requires proteolytic cleavage of the N-terminal prepro-region of the precursor. In contrast to previously characterized conopeptide toxins, the precursor of &#x003b1;B-VxXXIVA has no &#x02018;&#x02018;pro&#x02019;&#x02019; region. The putative proteolytic processing site between prepropeptide and mature region for conotoxins is usually a basic amino acid (K or R). In contrast, the predicted cleavage site for the &#x003b1;B-VxXXIVA precursor is &#x02013;LG- (<xref ref-type="fig" rid="pone-0054648-g001">Fig. 1</xref>). The predicted mature peptide exhibited a new cysteine framework, not previously reported for conotoxins, C&#x02013;CC&#x02013;C (<xref ref-type="table" rid="pone-0054648-t002">Table 2</xref> and <xref ref-type="supplementary-material" rid="pone.0054648.s007">Table S2</xref>). The predicted mature toxin sequence was VRCLEKSGAQPNKLFRPPCCQKGPSFARHSRCVYYTQSRE.</p><fig id="pone-0054648-g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0054648.g001</object-id><label>Figure 1</label><caption><title>&#x003b1;B-Conotoxin VxXXIVA prepeptide and encoded toxin are shown.</title><p>A putative proteolytic processing site (G) is indicated by the arrow. The mature toxin region is underlined. The stop codon is indicated as *. Unlike previously reported conotoxins, there is no pro region.</p></caption><graphic xlink:href="pone.0054648.g001"/></fig><table-wrap id="pone-0054648-t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0054648.t002</object-id><label>Table 2</label><caption><title>Mature toxin sequences of nAChR-targeted conotoxin superfamilies <xref rid="pone.0054648-Luo3" ref-type="bibr">[62]</xref>&#x02013;<xref rid="pone.0054648-Shon1" ref-type="bibr">[68]</xref>.</title></caption><alternatives><graphic id="pone-0054648-t002-2" xlink:href="pone.0054648.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Peptide</td><td align="left" rowspan="1" colspan="1">Superfamily</td><td align="left" rowspan="1" colspan="1">Mass</td><td align="left" rowspan="1" colspan="1">Cysteine Residues</td><td align="left" rowspan="1" colspan="1">Sequence</td><td align="left" rowspan="1" colspan="1">Reference</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">&#x003b1;B-VxXXIVA</td><td align="left" rowspan="1" colspan="1">B</td><td align="left" rowspan="1" colspan="1">4623</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">VR<bold>C</bold>LEKSGAQPNKLFRPP<bold>CC</bold>QKGPSFARHSR<bold>C</bold>VYYTQSR&#x000ca; 40aa</td><td align="left" rowspan="1" colspan="1">This Study</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x003b1;-AuIB</td><td align="left" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">1573</td><td align="left" rowspan="1" colspan="1">4</td><td align="left" rowspan="1" colspan="1">G<bold>CC</bold>SYPP<bold>C</bold>FATNPD<bold>C</bold># 15aa</td><td align="left" rowspan="1" colspan="1">62</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x003b1;A-OIVB</td><td align="left" rowspan="1" colspan="1">A</td><td align="left" rowspan="1" colspan="1">1865</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">
<bold>CC</bold>GVONAA<bold>C</bold>PO<bold>C</bold>V<bold>C</bold>NKT<bold>C</bold>G# 19aa</td><td align="left" rowspan="1" colspan="1">63</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x003b1;C-PrXA</td><td align="left" rowspan="1" colspan="1">T</td><td align="left" rowspan="1" colspan="1">3492</td><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">TYGIYDAKPOFS<bold>C</bold>AGLRGG<bold>C</bold>VLPONLROKFKE# 32aa</td><td align="left" rowspan="1" colspan="1">64</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x003b1;D-VxXIIA</td><td align="left" rowspan="1" colspan="1">D</td><td align="left" rowspan="1" colspan="1">5134</td><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">DVQD<bold>C</bold>QVSTOGSKWGR<bold>CC</bold>LNRV<bold>C</bold>GPM<bold>CC</bold>PASH<bold>C</bold>Y<bold>C</bold>VYHRGRGHG<bold>C</bold>S<bold>C</bold>? 47aa</td><td align="left" rowspan="1" colspan="1">65,66</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x003b1;S-RVIIIA</td><td align="left" rowspan="1" colspan="1">S</td><td align="left" rowspan="1" colspan="1">5168</td><td align="left" rowspan="1" colspan="1">10</td><td align="left" rowspan="1" colspan="1">K<bold>C</bold>NFDK<bold>C</bold>KGTGVYN<bold>C</bold>GXS<bold>C</bold>S<bold>C</bold>XGLHS<bold>C</bold>R<bold>C</bold>TYNIGSMKSG<bold>C</bold>A<bold>C</bold>I<bold>C</bold>TY&#x00176; 47aa</td><td align="left" rowspan="1" colspan="1">67</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x003c8;-PIIIE</td><td align="left" rowspan="1" colspan="1">M</td><td align="left" rowspan="1" colspan="1">2716</td><td align="left" rowspan="1" colspan="1">6</td><td align="left" rowspan="1" colspan="1">HOO<bold>CC</bold>LYGK<bold>C</bold>RRYOG<bold>C</bold>SSAS<bold>CC</bold>QR# 24aa</td><td align="left" rowspan="1" colspan="1">68</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt101"><label/><p>O&#x0200a;=&#x0200a;hydroxyproline, X&#x0200a;=&#x0200a;gamma-carboxyglutamate, #&#x0200a;=&#x0200a;C-terminus amidation,</p></fn><fn id="nt102"><label>&#x02227;</label><p>&#x0200a;=&#x0200a;C-terminus COOH.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3b"><title>Chemical Synthesis and Oxidative Folding of VxXXXIVA</title><p>With four Cys residues there are three possible disulfide bond arrangements:Cys3-Cys19, Cys20-Cys32 (&#x003b1;B-VxXXIVA <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>, <xref rid="pone.0054648-Espiritu1" ref-type="bibr">[2]</xref>); Cys3-Cys20, Cys19-Cys32 (&#x003b1;B-VxXXIVA <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>, <xref rid="pone.0054648-Norton1" ref-type="bibr">[3]</xref>), and Cys3-Cys32, Cys19-Cys20 &#x003b1;B-VxXXIVA <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>, <xref rid="pone.0054648-Daly1" ref-type="bibr">[4]</xref> (<xref ref-type="fig" rid="pone-0054648-g002">Fig. 2</xref>). Fmoc chemistry was used to synthesize the linear &#x003b1;B-VxXXIVA peptides. The cysteine side chains were protected in pairs with orthogonal protecting groups that could be removed selectively under different conditions, allowing the formation of one disulfide bridge at a time. The first and second, first and third, or second and third cysteine residues were protected with acid-labile groups, which were simultaneously removed during cleavage from the resin. Ferricyanide was used to close the first disulfide bridge. Reverse-phase HPLC was used to purify the monocyclic peptide; subsequently, the acid-stable acetometomethyl groups were removed from the remaining two cysteines by iodine oxidation, which also closed the second disulfide bridge. The three fully folded peptide isomers were individually purified by HPLC. Electrospray mass spectrometry was utilized to confirm the identity of the products. The monoisotopic masses in Da were: calculated, 4622.27; observed 4622.3 (&#x003b1;B-VxXXIVA <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>, <xref rid="pone.0054648-Espiritu1" ref-type="bibr">[2]</xref>), 4622.2 (&#x003b1;B-VxXXIVA <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>, <xref rid="pone.0054648-Norton1" ref-type="bibr">[3]</xref>), and 4622.4 (&#x003b1;B-VxXXIVA <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>, <xref rid="pone.0054648-Daly1" ref-type="bibr">[4]</xref>). Synthetic peptides with these disulfide bond arrangements were used in all subsequent studies.</p><fig id="pone-0054648-g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0054648.g002</object-id><label>Figure 2</label><caption><title>Amino acid sequence of &#x003b1;B-Conotoxin VxXXIVA.</title><p>Three possible isomers with different disulfide connectivities: &#x003b1;B-VxXXIVA <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>, <xref rid="pone.0054648-Espiritu1" ref-type="bibr">[2]</xref> with a disulfide connectivity I&#x02013;II, III&#x02013;IV; &#x003b1;B-VxXXIVA <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>, <xref rid="pone.0054648-Norton1" ref-type="bibr">[3]</xref> with I&#x02013;III, II&#x02013;IV and &#x003b1;B-VxXXIVA <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>, <xref rid="pone.0054648-Daly1" ref-type="bibr">[4]</xref> with I&#x02013;IV, II&#x02013;III.</p></caption><graphic xlink:href="pone.0054648.g002"/></fig></sec><sec id="s3c"><title>Effect of Conotoxin &#x003b1;B-VxXXIVA on nAChR ACh-evoked Currents</title><p>ACh is used in neurotransmission in the prey of <italic>Conus</italic> and nAChR antagonists are prevalent components of cone snail venoms. We therefore tested the &#x003b1;B-VxXXIVA isomers on subtypes of nAChRs. Pairwise combinations of nAChR subunits were heterologously expressed in <italic>Xenopus</italic> oocytes (<xref ref-type="table" rid="pone-0054648-t003">Table 3</xref>). The toxins were individually tested on these subtypes for their ability to antagonize the response elicited by ACh. Screening was performed initially at 10 &#x000b5;M concentration. <xref ref-type="fig" rid="pone-0054648-g003">Fig. 3A</xref> shows representative responses to ACh of &#x003b1;9&#x003b1;10 nAChRs in the presence and absence of &#x003b1;B-VxXXIVA <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>, <xref rid="pone.0054648-Espiritu1" ref-type="bibr">[2]</xref>. The block of &#x003b1;9&#x003b1;10 nAChR by &#x003b1;B-VxXXIVA <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>, <xref rid="pone.0054648-Espiritu1" ref-type="bibr">[2]</xref> was rapidly reversible. The most potent activity was observed at the &#x003b1;9&#x003b1;10 nAChR subtype (<xref ref-type="fig" rid="pone-0054648-g003">Fig. 3B</xref>). Concentration response experiments were then conducted. The IC<sub>50</sub> of &#x003b1;B-VxXXIVA <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>, <xref rid="pone.0054648-Espiritu1" ref-type="bibr">[2]</xref> at the &#x003b1;9&#x003b1;10 nAChR subtype was 1.2 (0.8&#x02013;1.7) &#x000b5;M. The concentration response for &#x003b1;B-VxXXIVA <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>, <xref rid="pone.0054648-Espiritu1" ref-type="bibr">[2]</xref> was subsequently assessed on each of the other expressed nAChR subtypes, <xref ref-type="fig" rid="pone-0054648-g004">Fig. 4</xref> and <xref ref-type="table" rid="pone-0054648-t003">Table 3</xref>. <xref ref-type="fig" rid="pone-0054648-g004">Fig. 4</xref> shows representative responses to ACh of &#x003b1;9&#x003b1;10, &#x003b1;7, &#x003b1;3&#x003b2;4 and &#x003b1;4&#x003b2;2 nAChRs in the presence and absence of &#x003b1;B-VxXXIVA <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>, <xref rid="pone.0054648-Espiritu1" ref-type="bibr">[2]</xref>. &#x003b1;B-VxXXIVA <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>, <xref rid="pone.0054648-Norton1" ref-type="bibr">[3]</xref> was less potent than &#x003b1;B-VxXXIVA <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>, <xref rid="pone.0054648-Espiritu1" ref-type="bibr">[2]</xref> on &#x003b1;9&#x003b1;10 nAChRs with an IC<sub>50</sub> of 3.9 (2.7&#x02013;5.6) &#x000b5;M. Like &#x003b1;B-VxXXIVA <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>, <xref rid="pone.0054648-Espiritu1" ref-type="bibr">[2]</xref>, &#x003b1;B-VxXXIVA <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>, <xref rid="pone.0054648-Norton1" ref-type="bibr">[3]</xref> had little or no activity on other tested nAChR subtypes (IC<sub>50</sub>&#x0003e;30 &#x000b5;M for &#x003b1;2&#x003b2;2, &#x003b1;2&#x003b2;4,&#x003b1;3&#x003b2;2,&#x003b1;3&#x003b2;4,&#x003b1;4&#x003b2;2, &#x003b1;4&#x003b2;4,&#x003b1;6/&#x003b1;3&#x003b2;2&#x003b2;3,&#x003b1;6/&#x003b1;3&#x003b2;4 and &#x003b1;7 nAChRs). &#x003b1;B-VxXXIVA <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>, <xref rid="pone.0054648-Daly1" ref-type="bibr">[4]</xref> blocked less than 15% of the &#x003b1;9&#x003b1;10 current at the highest concentration tested (30 &#x000b5;M). Likewise, it was inactive at other major nAChR subtypes including &#x003b1;3&#x003b2;4,&#x003b1;4&#x003b2;2 and &#x003b1;7 nAChRs (IC<sub>50</sub>&#x0003e;30 &#x000b5;M).</p><fig id="pone-0054648-g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0054648.g003</object-id><label>Figure 3</label><caption><title>&#x003b1;B-Conotoxin VxXXIVA blocks &#x003b1;9&#x003b1;10 nAChRs.</title><p>(<bold>A</bold>) <italic>Xenopus</italic> oocytes expressing &#x003b1;9&#x003b1;10 nAChR were voltage clamped at &#x02013;70 mV and subjected to a 1 s pulse of ACh every min as described in <italic>Materials and Methods</italic>. A representative response in a single oocyte is shown. After control responses to ACh, the oocyte was exposed to 10 &#x000b5;M toxin for 5 min (arrow). After the 5 min toxin application, a response to ACh was measured (a). After 1 min of toxin washout, another response to ACh was measured (b). Note that the response to ACh recovered to control level after 1 min of toxin washout. (<bold>B</bold>) Concentration response of &#x003b1;9&#x003b1;10 nAChRs exposed to the three different isomers of &#x003b1;B-VxXXIVA (see <xref ref-type="fig" rid="pone-0054648-g002">Fig 2</xref>). Values shown in the graph are mean &#x000b1; SEM from 3&#x02013;5 separate oocytes. The IC<sub>50</sub>s were: &#x003b1;B-VxXXIVA <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>, <xref rid="pone.0054648-Espiritu1" ref-type="bibr">[2]</xref>, 1.2 &#x000b5;M (0.8&#x02013;1.7 &#x000b5;M); &#x003b1;B-VxXXIVA <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>, <xref rid="pone.0054648-Norton1" ref-type="bibr">[3]</xref>, 3.9 &#x000b5;M (2.7&#x02013;5.6 &#x000b5;M); and &#x003b1;B-VxXXIVA <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>, <xref rid="pone.0054648-Daly1" ref-type="bibr">[4]</xref> &#x0003e;30 &#x000b5;M. Hill slopes were &#x003b1;B-VxXXIVA <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>, <xref rid="pone.0054648-Espiritu1" ref-type="bibr">[2]</xref>, 1.4 (0.5&#x02013;2.1) and &#x003b1;B-VxXXIVA <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>, <xref rid="pone.0054648-Norton1" ref-type="bibr">[3]</xref>, 1.3(0.9&#x02013;1.7).</p></caption><graphic xlink:href="pone.0054648.g003"/></fig><fig id="pone-0054648-g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0054648.g004</object-id><label>Figure 4</label><caption><title>&#x003b1;B-Conotoxin VxXXIVA differentially blocks &#x003b1;9&#x003b1;10, &#x003b1;7, &#x003b1;3&#x003b2;4 and &#x003b1;4&#x003b2;2 nAChRs.</title><p>nAChR subtypes were expressed as described in <italic>Materials and Methods</italic>. &#x0201c;C&#x0201d; indicates control responses to ACh. Oocytes were then exposed to 10 &#x000b5;M peptide for 5 min, followed by application of ACh. The peptide blocked &#x003b1;9&#x003b1;10 but not &#x003b1;<bold>7,</bold> &#x003b1;3&#x003b2;4 or &#x003b1;4&#x003b2;2 nAChRs.</p></caption><graphic xlink:href="pone.0054648.g004"/></fig><table-wrap id="pone-0054648-t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0054648.t003</object-id><label>Table 3</label><caption><title>IC50 and Hill slope values for block of rat nAChR subtypes by &#x003b1;B-Conotoxin VxXXIVA <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>, <xref rid="pone.0054648-Espiritu1" ref-type="bibr">[2]</xref>.</title></caption><alternatives><graphic id="pone-0054648-t003-3" xlink:href="pone.0054648.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">nAChR subtype</td><td align="left" rowspan="1" colspan="1">IC<sub>50</sub>
</td><td align="left" rowspan="1" colspan="1">IC<sub>50</sub> C.I.</td><td align="left" rowspan="1" colspan="1">Hill Slope</td><td align="left" rowspan="1" colspan="1">Hill Slope C.I.</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Rat &#x003b1;2&#x003b2;2</td><td align="left" rowspan="1" colspan="1">23.4 &#x000b5;M</td><td align="left" rowspan="1" colspan="1">17.3&#x02013;31.5 &#x000b5;M</td><td align="left" rowspan="1" colspan="1">1.1</td><td align="left" rowspan="1" colspan="1">0.7&#x02013;1.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Rat &#x003b1;2&#x003b2;4</td><td align="left" rowspan="1" colspan="1">&#x0003e;30 &#x000b5;M</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1">Rat &#x003b1;3&#x003b2;2</td><td align="left" rowspan="1" colspan="1">&#x0003e;30 &#x000b5;M</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1">Rat &#x003b1;3&#x003b2;4</td><td align="left" rowspan="1" colspan="1">&#x0003e;30 &#x000b5;M</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1">Rat &#x003b1;4&#x003b2;2</td><td align="left" rowspan="1" colspan="1">&#x0003e;30 &#x000b5;M</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1">Rat &#x003b1;4&#x003b2;4</td><td align="left" rowspan="1" colspan="1">&#x0003e;30 &#x000b5;M</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1">Rat &#x003b1;6/&#x003b1;3&#x003b2;2&#x003b2;3</td><td align="left" rowspan="1" colspan="1">12.2 &#x000b5;M</td><td align="left" rowspan="1" colspan="1">10.0&#x02013;14.9 &#x000b5;M</td><td align="left" rowspan="1" colspan="1">1.2</td><td align="left" rowspan="1" colspan="1">0.9&#x02013;1.7</td></tr><tr><td align="left" rowspan="1" colspan="1">Rat &#x003b1;6/&#x003b1;3&#x003b2;4</td><td align="left" rowspan="1" colspan="1">30.1 &#x000b5;M</td><td align="left" rowspan="1" colspan="1">18.8&#x02013;48.0 &#x000b5;M</td><td align="left" rowspan="1" colspan="1">1.0</td><td align="left" rowspan="1" colspan="1">0.5&#x02013;1.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Rat &#x003b1;7</td><td align="left" rowspan="1" colspan="1">&#x0003e;30 &#x000b5;M</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td><td align="left" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" rowspan="1" colspan="1">Rat &#x003b1;9&#x003b1;10</td><td align="left" rowspan="1" colspan="1">1.2 &#x000b5;M</td><td align="left" rowspan="1" colspan="1">0.8&#x02013;1.7 &#x000b5;M</td><td align="left" rowspan="1" colspan="1">1.4</td><td align="left" rowspan="1" colspan="1">0.5&#x02013;2.1</td></tr><tr><td align="left" rowspan="1" colspan="1">Mouse &#x003b1;1&#x003b2;1&#x003b3;&#x003b4;</td><td align="left" rowspan="1" colspan="1">6.6 &#x000b5;M</td><td align="left" rowspan="1" colspan="1">5.1&#x02013;8.5 &#x000b5;M</td><td align="left" rowspan="1" colspan="1">1.2</td><td align="left" rowspan="1" colspan="1">0.8&#x02013;1.6</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt103"><label/><p>C.I., 95% confidence interval.</p></fn></table-wrap-foot></table-wrap><p>&#x003b1;9&#x003b1;10 nAChRs are known to be highly permeable to calcium. Entry of Ca<sup>++</sup> through the nAChR elicits a response by Ca<sup>++</sup>-activated chloride currents. The magnitude of this response in <italic>Xenopus</italic> oocytes is large and can comprise &#x0003e;90% of the observed current. In contrast, the closely-related divalent cation Ba<sup>++</sup> does not elicit a response. We therefore assessed whether&#x003b1;B-VxXXIVA blocked the response to ACh when Ba<sup>++</sup> was substituted for Ca<sup>++</sup> in the buffer. Consistent with previous observations, the ACh response of &#x003b1;9&#x003b1;10 nAChRS in Ba<sup>++</sup> ND96 was substantially smaller than that observed in Ca<sup>++</sup> ND96 (data not shown). Using Ba<sup>++</sup> ND96, the &#x003b1;9&#x003b1;10 nAChR was most potently blocked by &#x003b1;B-VxXXIVA <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>, <xref rid="pone.0054648-Espiritu1" ref-type="bibr">[2]</xref> with an IC<sub>50</sub> of 1.49 &#x000b5;M; under these conditions, &#x003b1;B-VxXXIVA <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>, <xref rid="pone.0054648-Norton1" ref-type="bibr">[3]</xref> had an IC<sub>50</sub> of 3.15 &#x000b5;M and &#x003b1;B-VxXXIVA <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>, <xref rid="pone.0054648-Daly1" ref-type="bibr">[4]</xref> did not potently block the &#x003b1;9&#x003b1;10 nAChR subtype (<xref ref-type="fig" rid="pone-0054648-g005">Fig. 5</xref>). Thus, the potency of the &#x003b1;B-VxXXIVA isomers in the presence of Ba<sup>++</sup> was similar to that seen in Ca<sup>++</sup>, consistent with the toxin effect being due to blockade of the nAChR rather than blockade of the Ca<sup>++</sup>-activated Cl<sup>&#x02212;</sup> channel.</p><fig id="pone-0054648-g005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0054648.g005</object-id><label>Figure 5</label><caption><title>Concentration-response of &#x003b1;B-Conotoxin VxXXIVA on &#x003b1;9&#x003b1;10 nAChR in the presence of Ba<sup>++</sup>.</title><p>Equimolar Ba<sup>++</sup> was substituted for Ca<sup>++</sup>, in the perfusion solution as described in <italic>Materials and Methods</italic>, to prevent activation of endogenous <italic>Xenopus</italic> Ca<sup>++</sup> activated Cl<sup>&#x02212;</sup> currents. Values are mean &#x000b1; SEM from 3&#x02013;5 separate oocytes. The IC<sub>50</sub> for the &#x003b1;B-VxXXIVA isomer with disulfide connectivity of I-II; III-IV was 1.49 &#x000b5;M (1.18&#x02013;1.88) with Hill slope of 0.81 (0.66&#x02013;0.96). The IC<sub>50</sub> for the &#x003b1;B-VxXXIVA isomer with disulfide connectivity of I-III; II-IV was 3.15 &#x000b5;M (2.08&#x02013;4.78) with Hill slope of 0.64 (0.46&#x02013;0.81). Hill slopes (n<sub>H</sub>) were: Data points shown are the mean &#x000b1; SEM.</p></caption><graphic xlink:href="pone.0054648.g005"/></fig></sec><sec id="s3d"><title>NMR Studies</title><p>The 1D <sup>1</sup>H NMR spectra of &#x003b1;B-VxXXIVA isomers in phosphate buffer at pH 5.8 show that the majority of the amide protons fall within the 8.0&#x02013;9.0 ppm range (<xref ref-type="fig" rid="pone-0054648-g006">Fig. 6</xref>); the lack of chemical shift dispersion here and elsewhere in the spectrum indicates that these isomers lack any significant tertiary structure. The same was true at pH 7.0 (<xref ref-type="supplementary-material" rid="pone.0054648.s001">Fig. S1</xref>, <xref ref-type="supplementary-material" rid="pone.0054648.s002">S2</xref>, <xref ref-type="supplementary-material" rid="pone.0054648.s003">S3</xref>). NMR spectra were also acquired in the presence of 3&#x02013;10 mM CaCl<sub>2</sub> to ascertain whether calcium had any effect on their conformation, but no change in chemical shift dispersion was observed (<xref ref-type="supplementary-material" rid="pone.0054648.s004">Fig. S4</xref>).</p><fig id="pone-0054648-g006" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0054648.g006</object-id><label>Figure 6</label><caption><title>
<sup>1</sup>H NMR spectra of &#x003b1;B-Conotoxin VxXXIVA isomers.</title><p>Peptides were dissolved in 20 mM phosphate buffer at pH 5.8 and spectra were acquired at 600 MHz.</p></caption><graphic xlink:href="pone.0054648.g006"/></fig></sec><sec id="s3e"><title>Circular Dichroism Analysis</title><p>CD spectra were acquired on all three&#x003b1;B-VxXXIVA isomers in phosphate buffer. All peptide isomers exhibited minima at around 200 nm (<xref ref-type="fig" rid="pone-0054648-g007">Fig. 7A</xref>), indicative of a random coil conformation with no &#x003b1;-helical and &#x003b2;-sheet content, and consistent with our NMR results. As TFE is known to stabilize the &#x003b1;-helical structure in proteins and peptides <xref rid="pone.0054648-Corzo1" ref-type="bibr">[19]</xref>, CD spectra of one of the isomers (&#x003b1;B-VxXXIVA <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>, <xref rid="pone.0054648-Espiritu1" ref-type="bibr">[2]</xref>) were recorded in increasing concentrations of TFE. Upon addition of 50&#x02013;85% TFE, &#x003b1;B-VxXXIVA <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>, <xref rid="pone.0054648-Espiritu1" ref-type="bibr">[2]</xref> showed slightly increased ordered structure, as evident by the shift in the minimum towards 208 nm, with some ellipticity also developing at 222 nm (<xref ref-type="fig" rid="pone-0054648-g007">Fig. 7B</xref>). The CD data were fitted using three algorithms (CDSSTR, CONTINLL, and SELCON) in CDPro <xref rid="pone.0054648-Sreerama1" ref-type="bibr">[16]</xref>. The outputs obtained from all three algorithms gave very similar values and indicated that the &#x003b1;B-VxXXIVA <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>, <xref rid="pone.0054648-Espiritu1" ref-type="bibr">[2]</xref> isomer in the presence of 87% TFE had &#x0223c; 42% &#x003b1;-helix, &#x0223c; 8% &#x003b2;-strand and &#x0223c; 50% unordered structure (including turns), whereas, in the absence of TFE it had &#x0223c; 7% &#x003b1;-helix, &#x0223c; 31% &#x003b2;-strand and &#x0223c; 62% unordered structure.</p><fig id="pone-0054648-g007" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0054648.g007</object-id><label>Figure 7</label><caption><title>CD spectra &#x003b1;B-Conotoxin VxXXIVA isomers.</title><p>(<bold>A</bold>) Overlay of spectra in phosphate buffer. (<bold>B</bold>) CD spectrum of &#x003b1;B-VxXXIVA <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>, <xref rid="pone.0054648-Espiritu1" ref-type="bibr">[2]</xref> in the presence of 50 and 87% TFE. This isomer showed a propensity to adopt a partially helical conformation at high TFE concentrations as evident by the shift in the minimum towards 208 nm along with some ellipticity developing around 222 nm.</p></caption><graphic xlink:href="pone.0054648.g007"/></fig></sec></sec><sec id="s4"><title>Discussion</title><p>Conotoxins are a highly specialized set of disulfide-bonded peptides that are structurally and functionally diverse. Despite this diversity, toxins identified to date may be grouped into approximately 17 gene superfamilies based on conservation of the signal sequence. Within these gene superfamilies, the mature peptides adopt one of 23 patterns of arrangement of cysteine residues. Pharmacological targets within a gene superfamily may differ. For example, in the A superfamily, there are both paralytic and excitotoxic peptides <xref rid="pone.0054648-Santos1" ref-type="bibr">[20]</xref>.</p><p>It is very likely that the previously described superfamilies and Cys frameworks represent only a small fraction of the total chemical space of conotoxins. <italic>C. vexillum</italic> inhabits waters up to 70 m deep in Hainan province of the South China Sea and feeds on eunicid worms. Here, we describe the discovery and characterization from this species of &#x003b1;B-VxXXIVA, a peptide that differs in substantial aspects from previously-reported conotoxins.</p><p>The clone for &#x003b1;B-VxXXIVA was obtained from random sequencing of a cDNA library prepared from venom ducts. The signal sequence of &#x003b1;B-VxXXIVA does not align well with the signal sequence of other known conotoxins. Conservation of the signal sequence has previously been exploited as a means of cloning novel conotoxins from different species of cone snails <xref rid="pone.0054648-Han1" ref-type="bibr">[21]</xref>. The unique signal sequence of &#x003b1;B-VxXXIVA explains why this novel conotoxin has not been detected previously with screening primers designed to recognize known gene superfamilies. The discovery of &#x003b1;B-VxXXIVA expands the known complexity of this group of ion channel- and receptor-targeted ligands. Interestingly, the precursor for &#x003b1;B-VxXXIVA is unique among conotoxins in that it lacks a pro region. The pro region of disulfide-bonded peptides has been shown to facilitate oxidative folding <xref rid="pone.0054648-Hidaka1" ref-type="bibr">[22]</xref>. Consequently, the pro region of conotoxins was originally proposed as a means by which these peptides could fold into the same three-dimensional scaffold with identical disulfide connectivity <xref rid="pone.0054648-Woodward1" ref-type="bibr">[23]</xref>. However, evidence from studies with the two-disulfide &#x003b1;-conotoxin GI and three disulfide &#x003c9;-conotoxin MVIIA <xref rid="pone.0054648-PriceCarter1" ref-type="bibr">[24]</xref> indicates that the propeptide sequence does not necessarily contribute directly to folding thermodynamics but rather plays a facilitative role when folding is catalyzed by a disulfide isomerase <xref rid="pone.0054648-Buczek1" ref-type="bibr">[25]</xref>. The pro domain has also been implicated in the secretory pathway of hydrophobic O-superfamily conotoxins <xref rid="pone.0054648-Conticello1" ref-type="bibr">[26]</xref>. Apparently, such a mechanism is not necessary for the more hydrophilic &#x003b1;B-VxXXIVA.</p><p>The mature &#x003b1;B-VxXXIVA toxin is 40 amino acid residues in length and has a previously unreported arrangement of four Cys residues, C-CC-C. We synthesized the three possible disulfide isomers (<xref ref-type="fig" rid="pone-0054648-g002">Fig. 2</xref>) and assessed their activity at nAChRs. There are no reported examples of conotoxins that contain a vicinal disulfide bridge, and in the present case, the isomer that was synthesized with linkage between the adjacent second and third Cys residues was inactive. Both of the other two possible disulfide connectivities, &#x003b1;B-VxXXIVA <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>, <xref rid="pone.0054648-Espiritu1" ref-type="bibr">[2]</xref> with a disulfide connectivity I&#x02013;II, III&#x02013;IV, and &#x003b1;B-VxXXIVA <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>, <xref rid="pone.0054648-Norton1" ref-type="bibr">[3]</xref> with I&#x02013;III, II&#x02013;IV, blocked &#x003b1;&#x003b1;9&#x003b1;10 nAChRs, with the I&#x02013;II, III&#x02013;IV connectivity being 2-fold more active than the I&#x02013;III, II&#x02013;IV form.</p><p>There is precedent for conotoxins that selectively block the &#x003b1;9&#x003b1;10 over other nAChR subtypes. &#x003b1;-Conotoxin Vc1.1 from <italic>C. victoriae</italic> and &#x003b1;-conotoxin RgIA from <italic>C. regius</italic> block the &#x003b1;9&#x003b1;10 nAChR with IC<sub>50</sub> values of 5 and 19 nM, respectively <xref rid="pone.0054648-Vincler1" ref-type="bibr">[27]</xref>. Vc1.1 also blocks &#x003b1;6/&#x003b1;3&#x003b2;2&#x003b2;3 and &#x003b1;3&#x003b2;4 nAChRs with IC<sub>50</sub> values of 140 and 4200 nM, respectively. Both &#x003b1;-CTx Vc1.1 and &#x003b1;-CTx RgIA were subsequently found to activate GABA<sub>B</sub> receptors <xref rid="pone.0054648-Vincler1" ref-type="bibr">[27]</xref>, <xref rid="pone.0054648-Clark1" ref-type="bibr">[28]</xref>, <xref rid="pone.0054648-Callaghan1" ref-type="bibr">[29]</xref>. In addition, other conotoxins that block nAChRs have also been reported to block voltage-gated ion channels including sodium and potassium channels <xref rid="pone.0054648-Favreau1" ref-type="bibr">[30]</xref>, <xref rid="pone.0054648-Imperial1" ref-type="bibr">[31]</xref>. The IC<sub>50</sub> values for the &#x003b1;B-VxXXIVA isomers against &#x003b1;9&#x003b1;10 nAChRS are in the micromolar range. It is therefore possible that these peptides, in addition to blocking nAChRs, will subsequently be found to act on other ligand- or voltage-gated ion channels.</p><p>Although cone snails hunt fish, molluscs and worms, worms are the most common prey. The nAChR subunits from these polychaete marine worms have not been cloned; however, it is of note that &#x003b1;B-VxXXIVA preferentially targets the &#x003b1;9&#x003b1;10 subtype of nAChR. The &#x003b1;9 subunit is a member of the nAChR family although it is more distantly related; indeed it appears to be the closest subunit to the ancestor that gave rise to the nAChR family <xref rid="pone.0054648-Franchini1" ref-type="bibr">[32]</xref>. Thus, it is tempting to speculate that, among <italic>Conus</italic>, the worm-hunting species may be particularly likely to produce toxins that target &#x003b1;9 receptors.</p><p>The &#x003b1;9 subunit is also of increasing interest in biomedicine. Conotoxins that target the &#x003b1;9 nAChR have been shown to be analgesic <xref rid="pone.0054648-McIntosh1" ref-type="bibr">[10]</xref>, <xref rid="pone.0054648-Vincler1" ref-type="bibr">[27]</xref> and to accelerate the recovery of function after nerve injury, possibly through immune-mediated mechanisms <xref rid="pone.0054648-Satkunanathan1" ref-type="bibr">[33]</xref>, <xref rid="pone.0054648-Klimis1" ref-type="bibr">[34]</xref>. In addition, small molecule antagonists of &#x003b1;9&#x003b1;10 nAChRs are analgesic in models of neuropathic pain <xref rid="pone.0054648-Holtman1" ref-type="bibr">[35]</xref>, <xref rid="pone.0054648-Zheng1" ref-type="bibr">[36]</xref>.</p><p>The &#x003b1;9&#x003b1;10 receptor is present in keratinocytes and is implicated in the pathophysiology of wound healing <xref rid="pone.0054648-Chernyavsky1" ref-type="bibr">[37]</xref>. Recently it has been shown that the &#x003b1;9 subunit is overexpressed in breast cancer tissue. &#x003b1;9 antagonists reduce tumour growth <xref rid="pone.0054648-Lee1" ref-type="bibr">[38]</xref>, <xref rid="pone.0054648-Chen1" ref-type="bibr">[39]</xref>. Moreover, variants of the &#x003b1;9 subunit affect transformation and proliferation of bronchial cells <xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[1]</xref>, <xref rid="pone.0054648-Chikova1" ref-type="bibr">[40]</xref>. Thus, novel antagonists of the &#x003b1;9&#x003b1;10 nAChR are not only of value to structure/function analysis of this receptor subtype but may also help inform development of novel therapeutics.</p><p>The &#x003b1;B-VxXXIVA toxins are atypical among disulfide-bridged conotoxins in showing largely disordered structures in aqueous solution over a range of temperature and pH values. While unusual, this is consistent with structure predictions that show no significant ordered secondary structure for this amino acid sequence (<xref ref-type="supplementary-material" rid="pone.0054648.s005">Fig. S5</xref>); presumably this is also why the addition of a helix-stabilizing co-solvent like TFE did not induce significant helical structure in &#x003b1;B-VxXXIVA (<xref ref-type="fig" rid="pone-0054648-g007">Fig. 7</xref>). There are, however, precedents for disulfide-bridged conotoxins with poorly ordered structures and potent biological activity. Synthetic &#x003b1;&#x02212;AuIB, for example, formed both a globular (native) isomer and a ribbon isomer upon oxidative refolding, and the ribbon isomer, although having a less well-defined structure, had approximately 10 times greater potency than the native peptide on nACh-evoked currents in rat parasympathetic neurons <xref rid="pone.0054648-Dutton1" ref-type="bibr">[41]</xref>. More recently, three different disulfide-bridge isomers of the &#x003bc;-conotoxin PIIIA, which contains three disulfides, were found to block the skeletal muscle voltage-gated sodium channel Na<sub>V</sub>1.4 with similar, yet distinct potencies <xref rid="pone.0054648-Tietze1" ref-type="bibr">[42]</xref> even though one of them was disordered and gave a poorly dispersed <sup>1</sup>H NMR spectrum akin to those observed for all three &#x003b1;B-VxXXIVA disulfide isomers.</p><p>The concept of intrinsically disordered proteins is well established now <xref rid="pone.0054648-Dyson1" ref-type="bibr">[43]</xref>, although it is quite unusual to find a conotoxin containing two disulfide bridges that displays these properties, as in the case of &#x003b1;B-VxXXIVA. It is believed that most intrinsically disordered proteins adopt a more ordered structure upon binding to their physiological targets <xref rid="pone.0054648-Wright1" ref-type="bibr">[44]</xref>, although evidence is emerging that this is not always the case. It remains to be seen if &#x003b1;B-VxXXIVA becomes more ordered upon binding to &#x003b1;9&#x003b1;10 nAChR. This might be assessed by studying the interaction of ACh-binding proteins engineered to resemble the &#x003b1;9&#x003b1;10 nAChR <xref rid="pone.0054648-Nemecz1" ref-type="bibr">[45]</xref> and/or by creating conformationally constrained analogues of &#x003b1;B-VxXXIVA.</p></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0054648.s001"><label>Figure S1</label><caption><p>
<bold>The </bold>
<bold><italic>amide and aromatic region</italic></bold>
<bold> of <sup>1</sup>H </bold>
<bold><italic>NMR spectra</italic></bold>
<bold> of &#x003b1;B-VxXXIVA</bold>
<xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[<bold>1]</bold>
</xref>, <xref rid="pone.0054648-Espiritu1" ref-type="bibr">
<bold>[2]</bold>
</xref>
<bold>isomer at pH 5.8 and 7.0 in 20 mM phosphate buffer, acquired on a Varian 600 MHz NMR spectrometer at 22&#x000b0;C.</bold> Note that fewer amide resonances are observed at pH 7.0 because some are in rapid to intermediate exchange with solvent water at this pH.</p><p>(TIFF)</p></caption><media xlink:href="pone.0054648.s001.tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0054648.s002"><label>Figure S2</label><caption><p>
<bold>The </bold>
<bold><italic>amide and aromatic region</italic></bold>
<bold> of <sup>1</sup>H </bold>
<bold><italic>NMR spectra</italic></bold>
<bold> of &#x003b1;B-VxXXIVA</bold>
<xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[<bold>1]</bold>
</xref>, <xref rid="pone.0054648-Norton1" ref-type="bibr">
<bold>[3]</bold>
</xref>
<bold>isomer at pH 5.8 and 7.0 in 20 mM phosphate buffer, acquired on a Varian 600 MHz NMR spectrometer at 22&#x000b0;C.</bold> Note that fewer amide resonances are observed at pH 7.0 because some are in rapid to intermediate exchange with solvent water at this pH.</p><p>(TIFF)</p></caption><media xlink:href="pone.0054648.s002.tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0054648.s003"><label>Figure S3</label><caption><p>
<bold>The </bold>
<bold><italic>amide and aromatic region</italic></bold>
<bold> of <sup>1</sup>H </bold>
<bold><italic>NMR spectra</italic></bold>
<bold> of &#x003b1;B-VxXXIVA</bold>
<xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[<bold>1]</bold>
</xref>, <xref rid="pone.0054648-Daly1" ref-type="bibr">
<bold>[4]</bold>
</xref>
<bold>isomer at pH 5.8 and 7.0 in 20 mM phosphate buffer, acquired on a Varian 600 MHz NMR spectrometer at 22&#x000b0;C.</bold> Note that fewer amide resonances are observed at pH 7.0 because some are in rapid to intermediate exchange with solvent water at this pH.</p><p>(TIFF)</p></caption><media xlink:href="pone.0054648.s003.tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0054648.s004"><label>Figure S4</label><caption><p>
<bold><sup>1</sup>H NMR spectra of &#x003b1;B-VxXXIVA</bold>
<xref rid="pone.0054648-Albuquerque1" ref-type="bibr">[<bold>1]</bold>
</xref>, <xref rid="pone.0054648-Espiritu1" ref-type="bibr">
<bold>[2]</bold>
</xref>
<bold>in the presence and absence of CaCl<sub>2,</sub> in 90% H<sub>2</sub>O/10% <sup>2</sup>H<sub>2</sub>O at pH 5.5, acquired on a Varian 600 MHz NMR spectrometer at 22&#x000b0;C.</bold>
</p><p>(TIFF)</p></caption><media xlink:href="pone.0054648.s004.tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0054648.s005"><label>Figure S5</label><caption><p>
<bold>Secondary structure prediction of &#x003b1;B-VxXXIVA isomer, using the </bold>
<bold><italic>PSIPRED</italic></bold>
<bold> protein structure prediction </bold>
<bold><italic>server (</italic></bold>
<ext-link ext-link-type="uri" xlink:href="http://bioinf.cs.ucl.ac.uk/psipred/">http://bioinf.cs.ucl.ac.uk/psipred/</ext-link>
<bold><italic>).</italic></bold>
</p><p>(TIFF)</p></caption><media xlink:href="pone.0054648.s005.tiff"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0054648.s006"><label>Table S1</label><caption><p>
<bold>Alignment of protein precursor sequences of </bold>
<bold><italic>Conus</italic></bold>
<bold> gene superfamilies from </bold>
<xref ref-type="table" rid="pone-0054648-t001">
<bold>Table 1</bold>
</xref>
<bold>.</bold>
</p><p>(DOC)</p></caption><media xlink:href="pone.0054648.s006.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0054648.s007"><label>Table S2</label><caption><p>
<bold>Alignment of mature toxin sequences of nAChR targeted conotoxin superfamilies from </bold>
<xref ref-type="table" rid="pone-0054648-t002">
<bold>Table 2</bold>
</xref>
<bold>.</bold>
</p><p>(DOC)</p></caption><media xlink:href="pone.0054648.s007.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We thank Layla Azam, Olena Filchakova, Baldomero Olivera, Doju Yoshikami for advice and help.</p></ack><ref-list><title>References</title><ref id="pone.0054648-Albuquerque1"><label>1</label><mixed-citation publication-type="journal">
<name><surname>Albuquerque</surname><given-names>EX</given-names></name>, <name><surname>Pereira</surname><given-names>EF</given-names></name>, <name><surname>Alkondon</surname><given-names>M</given-names></name>, <name><surname>Rogers</surname><given-names>SW</given-names></name> (<year>2009</year>) <article-title>Mammalian nicotinic acetylcholine receptors: from structure to function</article-title>. <source>Physiol Rev</source>
<volume>89</volume>: <fpage>73</fpage>&#x02013;<lpage>120</lpage>.<pub-id pub-id-type="pmid">19126755</pub-id></mixed-citation></ref><ref id="pone.0054648-Espiritu1"><label>2</label><mixed-citation publication-type="journal">
<name><surname>Espiritu</surname><given-names>DJ</given-names></name>, <name><surname>Watkins</surname><given-names>M</given-names></name>, <name><surname>Dia-Monje</surname><given-names>V</given-names></name>, <name><surname>Cartier</surname><given-names>GE</given-names></name>, <name><surname>Cruz</surname><given-names>LJ</given-names></name>, <etal>et al</etal> (<year>2001</year>) <article-title>Venomous cone snails: molecular phylogeny and the generation of toxin diversity</article-title>. <source>Toxicon</source>
<volume>39</volume>: <fpage>1899</fpage>&#x02013;<lpage>1916</lpage>.<pub-id pub-id-type="pmid">11600154</pub-id></mixed-citation></ref><ref id="pone.0054648-Norton1"><label>3</label><mixed-citation publication-type="journal">
<name><surname>Norton</surname><given-names>RS</given-names></name>, <name><surname>Olivera</surname><given-names>BM</given-names></name> (<year>2006</year>) <article-title>Conotoxins down under</article-title>. <source>Toxicon</source>
<volume>48</volume>: <fpage>780</fpage>&#x02013;<lpage>798</lpage>.<pub-id pub-id-type="pmid">16952384</pub-id></mixed-citation></ref><ref id="pone.0054648-Daly1"><label>4</label><mixed-citation publication-type="journal">
<name><surname>Daly</surname><given-names>NL</given-names></name>, <name><surname>Craik</surname><given-names>DJ</given-names></name> (<year>2009</year>) <article-title>Structural studies of conotoxins</article-title>. <source>IUBMB Life</source>
<volume>61</volume>: <fpage>144</fpage>&#x02013;<lpage>150</lpage>.<pub-id pub-id-type="pmid">19165896</pub-id></mixed-citation></ref><ref id="pone.0054648-Olivera1"><label>5</label><mixed-citation publication-type="journal">
<name><surname>Olivera</surname><given-names>BM</given-names></name> (<year>2006</year>) <article-title>Conus peptides: biodiversity-based discovery and exogenomics</article-title>. <source>J Biol Chem</source>
<volume>281</volume>: <fpage>31173</fpage>&#x02013;<lpage>31177</lpage>.<pub-id pub-id-type="pmid">16905531</pub-id></mixed-citation></ref><ref id="pone.0054648-Armishaw1"><label>6</label><mixed-citation publication-type="journal">
<name><surname>Armishaw</surname><given-names>CJ</given-names></name>, <name><surname>Alewood</surname><given-names>PF</given-names></name> (<year>2005</year>) <article-title>Conotoxins as research tools and drug leads</article-title>. <source>Curr Protein Pept Sci</source>
<volume>6</volume>: <fpage>221</fpage>&#x02013;<lpage>240</lpage>.<pub-id pub-id-type="pmid">15974949</pub-id></mixed-citation></ref><ref id="pone.0054648-Kaas1"><label>7</label><mixed-citation publication-type="journal">
<name><surname>Kaas</surname><given-names>Q</given-names></name>, <name><surname>Yu</surname><given-names>R</given-names></name>, <name><surname>Jin</surname><given-names>AH</given-names></name>, <name><surname>Dutertre</surname><given-names>S</given-names></name>, <name><surname>Craik</surname><given-names>DJ</given-names></name> (<year>2012</year>) <article-title>ConoServer: updated content, knowledge, and discovery tools in the conopeptide database</article-title>. <source>Nucleic Acids Res</source>
<volume>40</volume>: <fpage>D325</fpage>&#x02013;<lpage>330</lpage>.<pub-id pub-id-type="pmid">22058133</pub-id></mixed-citation></ref><ref id="pone.0054648-Ye1"><label>8</label><mixed-citation publication-type="journal">
<name><surname>Ye</surname><given-names>M</given-names></name>, <name><surname>Khoo</surname><given-names>KK</given-names></name>, <name><surname>Xu</surname><given-names>S</given-names></name>, <name><surname>Zhou</surname><given-names>M</given-names></name>, <name><surname>Boonyalai</surname><given-names>N</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>A helical conotoxin from <italic>Conus imperialis</italic> has a novel cysteine framework and defines a new superfamily</article-title>. <source>J Biol Chem</source>
<volume>287</volume>: <fpage>14973</fpage>&#x02013;<lpage>14983</lpage>.<pub-id pub-id-type="pmid">22399292</pub-id></mixed-citation></ref><ref id="pone.0054648-Plazas1"><label>9</label><mixed-citation publication-type="journal">
<name><surname>Plazas</surname><given-names>PV</given-names></name>, <name><surname>Katz</surname><given-names>E</given-names></name>, <name><surname>Gomez-Casati</surname><given-names>ME</given-names></name>, <name><surname>Bouzat</surname><given-names>C</given-names></name>, <name><surname>Elgoyhen</surname><given-names>AB</given-names></name> (<year>2005</year>) <article-title>Stoichiometry of the alpha9alpha10 nicotinic cholinergic receptor</article-title>. <source>J Neurosci</source>
<volume>25</volume>: <fpage>10905</fpage>&#x02013;<lpage>10912</lpage>.<pub-id pub-id-type="pmid">16306403</pub-id></mixed-citation></ref><ref id="pone.0054648-McIntosh1"><label>10</label><mixed-citation publication-type="journal">
<name><surname>McIntosh</surname><given-names>JM</given-names></name>, <name><surname>Absalom</surname><given-names>N</given-names></name>, <name><surname>Chebib</surname><given-names>M</given-names></name>, <name><surname>Elgoyhen</surname><given-names>AB</given-names></name>, <name><surname>Vincler</surname><given-names>M</given-names></name> (<year>2009</year>) <article-title>Alpha9 nicotinic acetylcholine receptors and the treatment of pain</article-title>. <source>Biochem Pharmacol</source>
<volume>78</volume>: <fpage>693</fpage>&#x02013;<lpage>702</lpage>.<pub-id pub-id-type="pmid">19477168</pub-id></mixed-citation></ref><ref id="pone.0054648-Quan1"><label>11</label><mixed-citation publication-type="journal">
<name><surname>Quan</surname><given-names>Y</given-names></name>, <name><surname>Luo</surname><given-names>S</given-names></name>, <name><surname>Lin</surname><given-names>Q</given-names></name>, <name><surname>Zhangsun</surname><given-names>D</given-names></name>, <name><surname>Zhang</surname><given-names>B</given-names></name> (<year>2005</year>) <article-title>Conotoxin RNA isolation and its cDNA synthesis</article-title>. <source>Chin J Mar Drugs</source>
<volume>24</volume>: <fpage>1</fpage>&#x02013;<lpage>5</lpage>.</mixed-citation></ref><ref id="pone.0054648-Duckert1"><label>12</label><mixed-citation publication-type="journal">
<name><surname>Duckert</surname><given-names>P</given-names></name>, <name><surname>Brunak</surname><given-names>S</given-names></name>, <name><surname>Blom</surname><given-names>N</given-names></name> (<year>2004</year>) <article-title>Prediction of proprotein convertase cleavage sites</article-title>. <source>Protein Eng Des Sel</source>
<volume>17</volume>: <fpage>107</fpage>&#x02013;<lpage>112</lpage>.<pub-id pub-id-type="pmid">14985543</pub-id></mixed-citation></ref><ref id="pone.0054648-Dowell1"><label>13</label><mixed-citation publication-type="journal">
<name><surname>Dowell</surname><given-names>C</given-names></name>, <name><surname>Olivera</surname><given-names>BM</given-names></name>, <name><surname>Garrett</surname><given-names>JE</given-names></name>, <name><surname>Staheli</surname><given-names>ST</given-names></name>, <name><surname>Watkins</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2003</year>) <article-title>Alpha-conotoxin PIA is selective for alpha6 subunit-containing nicotinic acetylcholine receptors</article-title>. <source>J Neurosci</source>
<volume>23</volume>: <fpage>8445</fpage>&#x02013;<lpage>8452</lpage>.<pub-id pub-id-type="pmid">13679412</pub-id></mixed-citation></ref><ref id="pone.0054648-Cartier1"><label>14</label><mixed-citation publication-type="journal">
<name><surname>Cartier</surname><given-names>GE</given-names></name>, <name><surname>Yoshikami</surname><given-names>D</given-names></name>, <name><surname>Gray</surname><given-names>WR</given-names></name>, <name><surname>Luo</surname><given-names>S</given-names></name>, <name><surname>Olivera</surname><given-names>BM</given-names></name>, <etal>et al</etal> (<year>1996</year>) <article-title>A new alpha-conotoxin which targets alpha3beta2 nicotinic acetylcholine receptors</article-title>. <source>J Biol Chem</source>
<volume>271</volume>: <fpage>7522</fpage>&#x02013;<lpage>7528</lpage>.<pub-id pub-id-type="pmid">8631783</pub-id></mixed-citation></ref><ref id="pone.0054648-Hwang1"><label>15</label><mixed-citation publication-type="journal">
<name><surname>Hwang</surname><given-names>TL</given-names></name>, <name><surname>Shaka</surname><given-names>AJ</given-names></name> (<year>1995</year>) <article-title>Water suppression that works&#x02013;excitation sculpting using arbitrary wave-forms and pulsed-field gradients</article-title>. <source>J Magn Reson</source>
<volume>112</volume>: <fpage>275</fpage>&#x02013;<lpage>279</lpage>.</mixed-citation></ref><ref id="pone.0054648-Sreerama1"><label>16</label><mixed-citation publication-type="journal">
<name><surname>Sreerama</surname><given-names>N</given-names></name>, <name><surname>Woody</surname><given-names>RW</given-names></name> (<year>2000</year>) <article-title>Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set</article-title>. <source>Anal Biochem</source>
<volume>287</volume>: <fpage>252</fpage>&#x02013;<lpage>260</lpage>.<pub-id pub-id-type="pmid">11112271</pub-id></mixed-citation></ref><ref id="pone.0054648-Zhangsun1"><label>17</label><mixed-citation publication-type="journal">
<name><surname>Zhangsun</surname><given-names>D</given-names></name>, <name><surname>Luo</surname><given-names>S</given-names></name>, <name><surname>Wu</surname><given-names>Y</given-names></name>, <name><surname>Zhu</surname><given-names>X</given-names></name>, <name><surname>Hu</surname><given-names>Y</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Novel O-superfamily conotoxins identified by cDNA cloning from three vermivorous <italic>Conus</italic> species</article-title>. <source>Chem Biol Drug Des</source>
<volume>68</volume>: <fpage>256</fpage>&#x02013;<lpage>265</lpage>.<pub-id pub-id-type="pmid">17177885</pub-id></mixed-citation></ref><ref id="pone.0054648-Kaas2"><label>18</label><mixed-citation publication-type="journal">
<name><surname>Kaas</surname><given-names>Q</given-names></name>, <name><surname>Westermann</surname><given-names>JC</given-names></name>, <name><surname>Halai</surname><given-names>R</given-names></name>, <name><surname>Wang</surname><given-names>CK</given-names></name>, <name><surname>Craik</surname><given-names>DJ</given-names></name> (<year>2008</year>) <article-title>ConoServer, a database for conopeptide sequences and structures</article-title>. <source>Bioinformatics</source>
<volume>24</volume>: <fpage>445</fpage>&#x02013;<lpage>446</lpage>.<pub-id pub-id-type="pmid">18065428</pub-id></mixed-citation></ref><ref id="pone.0054648-Corzo1"><label>19</label><mixed-citation publication-type="journal">
<name><surname>Corzo</surname><given-names>G</given-names></name>, <name><surname>Escoubas</surname><given-names>P</given-names></name>, <name><surname>Villegas</surname><given-names>E</given-names></name>, <name><surname>Barnham</surname><given-names>KJ</given-names></name>, <name><surname>He</surname><given-names>W</given-names></name>, <etal>et al</etal> (<year>2001</year>) <article-title>Characterization of unique amphipathic antimicrobial peptides from venom of the scorpion <italic>Pandinus imperator</italic>
</article-title>. <source>Biochem J</source>
<volume>359</volume>: <fpage>35</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="pmid">11563967</pub-id></mixed-citation></ref><ref id="pone.0054648-Santos1"><label>20</label><mixed-citation publication-type="journal">
<name><surname>Santos</surname><given-names>AD</given-names></name>, <name><surname>McIntosh</surname><given-names>JM</given-names></name>, <name><surname>Hillyard</surname><given-names>DR</given-names></name>, <name><surname>Cruz</surname><given-names>LJ</given-names></name>, <name><surname>Olivera</surname><given-names>BM</given-names></name> (<year>2004</year>) <article-title>The A-superfamily of conotoxins: structural and functional divergence</article-title>. <source>J Biol Chem</source>
<volume>279</volume>: <fpage>17596</fpage>&#x02013;<lpage>17606</lpage>.<pub-id pub-id-type="pmid">14701840</pub-id></mixed-citation></ref><ref id="pone.0054648-Han1"><label>21</label><mixed-citation publication-type="journal">
<name><surname>Han</surname><given-names>TS</given-names></name>, <name><surname>Teichert</surname><given-names>RW</given-names></name>, <name><surname>Olivera</surname><given-names>BM</given-names></name>, <name><surname>Bulaj</surname><given-names>G</given-names></name> (<year>2008</year>) <article-title>Conus venoms - a rich source of peptide-based therapeutics</article-title>. <source>Curr Pharm Des</source>
<volume>14</volume>: <fpage>2462</fpage>&#x02013;<lpage>2479</lpage>.<pub-id pub-id-type="pmid">18781995</pub-id></mixed-citation></ref><ref id="pone.0054648-Hidaka1"><label>22</label><mixed-citation publication-type="journal">
<name><surname>Hidaka</surname><given-names>Y</given-names></name>, <name><surname>Ohno</surname><given-names>M</given-names></name>, <name><surname>Hemmasi</surname><given-names>B</given-names></name>, <name><surname>Hill</surname><given-names>O</given-names></name>, <name><surname>Forssmann</surname><given-names>WG</given-names></name>, <etal>et al</etal> (<year>1998</year>) <article-title>In vitro disulfide-coupled folding of guanylyl cyclase-activating peptide and its precursor protein</article-title>. <source>Biochemistry</source>
<volume>37</volume>: <fpage>8498</fpage>&#x02013;<lpage>8507</lpage>.<pub-id pub-id-type="pmid">9622502</pub-id></mixed-citation></ref><ref id="pone.0054648-Woodward1"><label>23</label><mixed-citation publication-type="journal">
<name><surname>Woodward</surname><given-names>SR</given-names></name>, <name><surname>Cruz</surname><given-names>LJ</given-names></name>, <name><surname>Olivera</surname><given-names>BM</given-names></name>, <name><surname>Hillyard</surname><given-names>DR</given-names></name> (<year>1990</year>) <article-title>Constant and hypervariable regions in conotoxin propeptides</article-title>. <source>EMBO J</source>
<volume>9</volume>: <fpage>1015</fpage>&#x02013;<lpage>1020</lpage>.<pub-id pub-id-type="pmid">1691090</pub-id></mixed-citation></ref><ref id="pone.0054648-PriceCarter1"><label>24</label><mixed-citation publication-type="journal">
<name><surname>Price-Carter</surname><given-names>M</given-names></name>, <name><surname>Gray</surname><given-names>WR</given-names></name>, <name><surname>Goldenberg</surname><given-names>DP</given-names></name> (<year>1996</year>) <article-title>Folding of omega-conotoxins. 1. Efficient disulfide-coupled folding of mature sequences in vitro</article-title>. <source>Biochemistry</source>
<volume>35</volume>: <fpage>15537</fpage>&#x02013;<lpage>15546</lpage>.<pub-id pub-id-type="pmid">8952508</pub-id></mixed-citation></ref><ref id="pone.0054648-Buczek1"><label>25</label><mixed-citation publication-type="journal">
<name><surname>Buczek</surname><given-names>O</given-names></name>, <name><surname>Olivera</surname><given-names>BM</given-names></name>, <name><surname>Bulaj</surname><given-names>G</given-names></name> (<year>2004</year>) <article-title>Propeptide does not act as an intramolecular chaperone but facilitates protein disulfide isomerase-assisted folding of a conotoxin precursor</article-title>. <source>Biochemistry</source>
<volume>43</volume>: <fpage>1093</fpage>&#x02013;<lpage>1101</lpage>.<pub-id pub-id-type="pmid">14744155</pub-id></mixed-citation></ref><ref id="pone.0054648-Conticello1"><label>26</label><mixed-citation publication-type="journal">
<name><surname>Conticello</surname><given-names>SG</given-names></name>, <name><surname>Kowalsman</surname><given-names>ND</given-names></name>, <name><surname>Jacobsen</surname><given-names>C</given-names></name>, <name><surname>Yudkovsky</surname><given-names>G</given-names></name>, <name><surname>Sato</surname><given-names>K</given-names></name>, <etal>et al</etal> (<year>2003</year>) <article-title>The prodomain of a secreted hydrophobic mini-protein facilitates its export from the endoplasmic reticulum by hitchhiking on sorting receptors</article-title>. <source>J Biol Chem</source>
<volume>278</volume>: <fpage>26311</fpage>&#x02013;<lpage>26314</lpage>.<pub-id pub-id-type="pmid">12771154</pub-id></mixed-citation></ref><ref id="pone.0054648-Vincler1"><label>27</label><mixed-citation publication-type="journal">
<name><surname>Vincler</surname><given-names>M</given-names></name>, <name><surname>Wittenauer</surname><given-names>S</given-names></name>, <name><surname>Parker</surname><given-names>R</given-names></name>, <name><surname>Ellison</surname><given-names>M</given-names></name>, <name><surname>Olivera</surname><given-names>BM</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Molecular mechanism for analgesia involving specific antagonism of alpha9alpha10 nicotinic acetylcholine receptors</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>103</volume>: <fpage>17880</fpage>&#x02013;<lpage>17884</lpage>.<pub-id pub-id-type="pmid">17101979</pub-id></mixed-citation></ref><ref id="pone.0054648-Clark1"><label>28</label><mixed-citation publication-type="journal">
<name><surname>Clark</surname><given-names>RJ</given-names></name>, <name><surname>Fischer</surname><given-names>H</given-names></name>, <name><surname>Nevin</surname><given-names>ST</given-names></name>, <name><surname>Adams</surname><given-names>DJ</given-names></name>, <name><surname>Craik</surname><given-names>DJ</given-names></name> (<year>2006</year>) <article-title>The synthesis, structural characterization, and receptor specificity of the alpha-conotoxin Vc1.1</article-title>. <source>J Biol Chem</source>
<volume>281</volume>: <fpage>23254</fpage>&#x02013;<lpage>23263</lpage>.<pub-id pub-id-type="pmid">16754662</pub-id></mixed-citation></ref><ref id="pone.0054648-Callaghan1"><label>29</label><mixed-citation publication-type="journal">
<name><surname>Callaghan</surname><given-names>B</given-names></name>, <name><surname>Haythornthwaite</surname><given-names>A</given-names></name>, <name><surname>Berecki</surname><given-names>G</given-names></name>, <name><surname>Clark</surname><given-names>RJ</given-names></name>, <name><surname>Craik</surname><given-names>DJ</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Analgesic alpha-conotoxins Vc1.1 and Rg1A inhibit N-type calcium channels in rat sensory neurons via GABAB receptor activation</article-title>. <source>J Neurosci</source>
<volume>28</volume>: <fpage>10943</fpage>&#x02013;<lpage>10951</lpage>.<pub-id pub-id-type="pmid">18945902</pub-id></mixed-citation></ref><ref id="pone.0054648-Favreau1"><label>30</label><mixed-citation publication-type="journal">
<name><surname>Favreau</surname><given-names>P</given-names></name>, <name><surname>Benoit</surname><given-names>E</given-names></name>, <name><surname>Hocking</surname><given-names>HG</given-names></name>, <name><surname>Carlier</surname><given-names>L</given-names></name>, <name><surname>D' hoedt</surname><given-names>D</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>A novel &#x000b5;-conopeptide, CnIIIC, exerts potent and preferential inhibition of Nav1.2/1.4 channels and blocks neuronal nicotinic acetylcholine receptors</article-title>. <source>Br J Pharmacol</source>
<volume>166</volume>: <fpage>1654</fpage>&#x02013;<lpage>68</lpage>.<pub-id pub-id-type="pmid">22229737</pub-id></mixed-citation></ref><ref id="pone.0054648-Imperial1"><label>31</label><mixed-citation publication-type="journal">
<name><surname>Imperial</surname><given-names>JS</given-names></name>, <name><surname>Bansal</surname><given-names>PS</given-names></name>, <name><surname>Alewood</surname><given-names>PF</given-names></name>, <name><surname>Daly</surname><given-names>NL</given-names></name>, <name><surname>Craik</surname><given-names>DJ</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>A novel conotoxin inhibitor of Kv1.6 channel and nAChR subtypes defines a new superfamily of conotoxins</article-title>. <source>Biochemistry</source>
<volume>45</volume>: <fpage>8331</fpage>&#x02013;<lpage>8340</lpage>.<pub-id pub-id-type="pmid">16819832</pub-id></mixed-citation></ref><ref id="pone.0054648-Franchini1"><label>32</label><mixed-citation publication-type="journal">
<name><surname>Franchini</surname><given-names>LF</given-names></name>, <name><surname>Elgoyhen</surname><given-names>AB</given-names></name> (<year>2006</year>) <article-title>Adaptive evolution in mammalian proteins involved in cochlear outer hair cell electromotility</article-title>. <source>Mol Phylogenet Evol</source>
<volume>41</volume>: <fpage>622</fpage>&#x02013;<lpage>635</lpage>.<pub-id pub-id-type="pmid">16854604</pub-id></mixed-citation></ref><ref id="pone.0054648-Satkunanathan1"><label>33</label><mixed-citation publication-type="journal">
<name><surname>Satkunanathan</surname><given-names>N</given-names></name>, <name><surname>Livett</surname><given-names>B</given-names></name>, <name><surname>Gayler</surname><given-names>K</given-names></name>, <name><surname>Sandall</surname><given-names>D</given-names></name>, <name><surname>Down</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Alpha-conotoxin Vc1.1 alleviates neuropathic pain and accelerates functional recovery of injured neurones</article-title>. <source>Brain Res</source>
<volume>1059</volume>: <fpage>149</fpage>&#x02013;<lpage>158</lpage>.<pub-id pub-id-type="pmid">16182258</pub-id></mixed-citation></ref><ref id="pone.0054648-Klimis1"><label>34</label><mixed-citation publication-type="journal">
<name><surname>Klimis</surname><given-names>H</given-names></name>, <name><surname>Adams</surname><given-names>DJ</given-names></name>, <name><surname>Callaghan</surname><given-names>B</given-names></name>, <name><surname>Nevin</surname><given-names>S</given-names></name>, <name><surname>Alewood</surname><given-names>PF</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>A novel mechanism of inhibition of high-voltage activated calcium channels by alpha-conotoxins contributes to relief of nerve injury-induced neuropathic pain</article-title>. <source>Pain</source>
<volume>152</volume>: <fpage>259</fpage>&#x02013;<lpage>266</lpage>.<pub-id pub-id-type="pmid">20889259</pub-id></mixed-citation></ref><ref id="pone.0054648-Holtman1"><label>35</label><mixed-citation publication-type="journal">
<name><surname>Holtman</surname><given-names>JR</given-names></name>, <name><surname>Dwoskin</surname><given-names>LP</given-names></name>, <name><surname>Dowell</surname><given-names>C</given-names></name>, <name><surname>Wala</surname><given-names>EP</given-names></name>, <name><surname>Zhang</surname><given-names>Z</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>The novel small molecule alpha9alpha10 nicotinic acetylcholine receptor antagonist ZZ-204G is analgesic</article-title>. <source>Eur J Pharmacol</source>
<volume>670</volume>: <fpage>500</fpage>&#x02013;<lpage>508</lpage>.<pub-id pub-id-type="pmid">21944926</pub-id></mixed-citation></ref><ref id="pone.0054648-Zheng1"><label>36</label><mixed-citation publication-type="journal">
<name><surname>Zheng</surname><given-names>G</given-names></name>, <name><surname>Zhang</surname><given-names>Z</given-names></name>, <name><surname>Dowell</surname><given-names>C</given-names></name>, <name><surname>Wala</surname><given-names>E</given-names></name>, <name><surname>Dwoskin</surname><given-names>LP</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Discovery of non-peptide, small molecule antagonists of alpha9alpha10 nicotinic acetylcholine receptors as novel analgesics for the treatment of neuropathic and tonic inflammatory pain</article-title>. <source>Bioorg Med Chem Lett</source>
<volume>21</volume>: <fpage>2476</fpage>&#x02013;<lpage>2479</lpage>.<pub-id pub-id-type="pmid">21397497</pub-id></mixed-citation></ref><ref id="pone.0054648-Chernyavsky1"><label>37</label><mixed-citation publication-type="journal">
<name><surname>Chernyavsky</surname><given-names>AI</given-names></name>, <name><surname>Arredondo</surname><given-names>J</given-names></name>, <name><surname>Vetter</surname><given-names>DE</given-names></name>, <name><surname>Grando</surname><given-names>SA</given-names></name> (<year>2007</year>) <article-title>Central role of alpha9 acetylcholine receptor in coordinating keratinocyte adhesion and motility at the initiation of epithelialization</article-title>. <source>Exp Cell Res</source>
<volume>313</volume>: <fpage>3542</fpage>&#x02013;<lpage>3555</lpage>.<pub-id pub-id-type="pmid">17706194</pub-id></mixed-citation></ref><ref id="pone.0054648-Lee1"><label>38</label><mixed-citation publication-type="journal">
<name><surname>Lee</surname><given-names>CH</given-names></name>, <name><surname>Huang</surname><given-names>CS</given-names></name>, <name><surname>Chen</surname><given-names>CS</given-names></name>, <name><surname>Tu</surname><given-names>SH</given-names></name>, <name><surname>Wang</surname><given-names>YJ</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Overexpression and activation of the alpha9-nicotinic receptor during tumorigenesis in human breast epithelial cells</article-title>. <source>J Natl Cancer Inst</source>
<volume>102</volume>: <fpage>1322</fpage>&#x02013;<lpage>1335</lpage>.<pub-id pub-id-type="pmid">20733118</pub-id></mixed-citation></ref><ref id="pone.0054648-Chen1"><label>39</label><mixed-citation publication-type="journal">
<name><surname>Chen</surname><given-names>CS</given-names></name>, <name><surname>Lee</surname><given-names>CH</given-names></name>, <name><surname>Hsieh</surname><given-names>CD</given-names></name>, <name><surname>Ho</surname><given-names>CT</given-names></name>, <name><surname>Pan</surname><given-names>MH</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Nicotine-induced human breast cancer cell proliferation attenuated by garcinol through down-regulation of the nicotinic receptor and cyclin D3 proteins</article-title>. <source>Breast Cancer Res Treat</source>
<volume>125</volume>: <fpage>73</fpage>&#x02013;<lpage>87</lpage>.<pub-id pub-id-type="pmid">20229177</pub-id></mixed-citation></ref><ref id="pone.0054648-Chikova1"><label>40</label><mixed-citation publication-type="journal">
<name><surname>Chikova</surname><given-names>A</given-names></name>, <name><surname>Grando</surname><given-names>SA</given-names></name> (<year>2011</year>) <article-title>Naturally occurring variants of human Alpha9 nicotinic receptor differentially affect bronchial cell proliferation and transformation</article-title>. <source>PLoS One</source>
<volume>6</volume>: <fpage>e27978</fpage>.<pub-id pub-id-type="pmid">22125646</pub-id></mixed-citation></ref><ref id="pone.0054648-Dutton1"><label>41</label><mixed-citation publication-type="journal">
<name><surname>Dutton</surname><given-names>JL</given-names></name>, <name><surname>Bansal</surname><given-names>PS</given-names></name>, <name><surname>Hogg</surname><given-names>RC</given-names></name>, <name><surname>Adams</surname><given-names>DJ</given-names></name>, <name><surname>Alewood</surname><given-names>PF</given-names></name>, <etal>et al</etal> (<year>2002</year>) <article-title>A new level of conotoxin diversity, a non-native disulfide bond connectivity in alpha-conotoxin AuIB reduces structural definition but increases biological activity</article-title>. <source>J Biol Chem</source>
<volume>277</volume>: <fpage>48849</fpage>&#x02013;<lpage>48857</lpage>.<pub-id pub-id-type="pmid">12376538</pub-id></mixed-citation></ref><ref id="pone.0054648-Tietze1"><label>42</label><mixed-citation publication-type="journal">
<name><surname>Tietze</surname><given-names>AA</given-names></name>, <name><surname>Tietze</surname><given-names>D</given-names></name>, <name><surname>Ohlenschlager</surname><given-names>O</given-names></name>, <name><surname>Leipold</surname><given-names>E</given-names></name>, <name><surname>Ullrich</surname><given-names>F</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Structurally diverse mu-conotoxin PIIIA isomers block sodium channel NaV 1.4</article-title>. <source>Angew Chem Int Ed Engl</source>
<volume>51</volume>: <fpage>4058</fpage>&#x02013;<lpage>4061</lpage>.<pub-id pub-id-type="pmid">22407516</pub-id></mixed-citation></ref><ref id="pone.0054648-Dyson1"><label>43</label><mixed-citation publication-type="journal">
<name><surname>Dyson</surname><given-names>HJ</given-names></name> (<year>2011</year>) <article-title>Expanding the proteome: disordered and alternatively folded proteins</article-title>. <source>Q Rev Biophys</source>
<volume>44</volume>: <fpage>467</fpage>&#x02013;<lpage>518</lpage>.<pub-id pub-id-type="pmid">21729349</pub-id></mixed-citation></ref><ref id="pone.0054648-Wright1"><label>44</label><mixed-citation publication-type="journal">
<name><surname>Wright</surname><given-names>PE</given-names></name>, <name><surname>Dyson</surname><given-names>HJ</given-names></name> (<year>2009</year>) <article-title>Linking folding and binding</article-title>. <source>Curr Opin Struct Biol</source>
<volume>19</volume>: <fpage>31</fpage>&#x02013;<lpage>38</lpage>.<pub-id pub-id-type="pmid">19157855</pub-id></mixed-citation></ref><ref id="pone.0054648-Nemecz1"><label>45</label><mixed-citation publication-type="journal">
<name><surname>Nemecz</surname><given-names>A</given-names></name>, <name><surname>Taylor</surname><given-names>P</given-names></name> (<year>2011</year>) <article-title>Creating an alpha7 nicotinic acetylcholine recognition domain from the acetylcholine-binding protein: crystallographic and ligand selectivity analyses</article-title>. <source>J Biol Chem</source>
<volume>286</volume>: <fpage>42555</fpage>&#x02013;<lpage>42565</lpage>.<pub-id pub-id-type="pmid">22009746</pub-id></mixed-citation></ref><ref id="pone.0054648-Luo1"><label>46</label><mixed-citation publication-type="journal">
<name><surname>Luo</surname><given-names>S</given-names></name>, <name><surname>Zhangsun</surname><given-names>D</given-names></name>, <name><surname>Feng</surname><given-names>J</given-names></name>, <name><surname>Wu</surname><given-names>Y</given-names></name>, <name><surname>Zhu</surname><given-names>X</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Diversity of the O-superfamily conotoxins from <italic>Conus miles.</italic>
</article-title>. <source>J Pept Sci</source>
<volume>13</volume>: <fpage>44</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="pmid">17106905</pub-id></mixed-citation></ref><ref id="pone.0054648-Luo2"><label>47</label><mixed-citation publication-type="journal">
<name><surname>Luo</surname><given-names>S</given-names></name>, <name><surname>Akondi</surname><given-names>KB</given-names></name>, <name><surname>Zhangsun</surname><given-names>D</given-names></name>, <name><surname>Wu</surname><given-names>Y</given-names></name>, <name><surname>Zhu</surname><given-names>X</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Atypical alpha-conotoxin LtIA from <italic>Conus litteratus</italic> targets a novel microsite of the alpha3beta2 nicotinic receptor</article-title>. <source>J Biol Chem</source>
<volume>285</volume>: <fpage>12355</fpage>&#x02013;<lpage>12366</lpage>.<pub-id pub-id-type="pmid">20145249</pub-id></mixed-citation></ref><ref id="pone.0054648-Pi1"><label>48</label><mixed-citation publication-type="journal">
<name><surname>Pi</surname><given-names>C</given-names></name>, <name><surname>Liu</surname><given-names>J</given-names></name>, <name><surname>Peng</surname><given-names>C</given-names></name>, <name><surname>Liu</surname><given-names>Y</given-names></name>, <name><surname>Jiang</surname><given-names>X</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Diversity and evolution of conotoxins based on gene expression profiling of Conus litteratus</article-title>. <source>Genomics</source>
<volume>88</volume>: <fpage>809</fpage>&#x02013;<lpage>819</lpage>.<pub-id pub-id-type="pmid">16908117</pub-id></mixed-citation></ref><ref id="pone.0054648-Loughnan1"><label>49</label><mixed-citation publication-type="journal">
<name><surname>Loughnan</surname><given-names>ML</given-names></name>, <name><surname>Nicke</surname><given-names>A</given-names></name>, <name><surname>Lawrence</surname><given-names>N</given-names></name>, <name><surname>Lewis</surname><given-names>RJ</given-names></name> (<year>2009</year>) <article-title>Novel alpha D-conopeptides and their precursors identified by cDNA cloning define the D-conotoxin superfamily</article-title>. <source>Biochemistry</source>
<volume>48</volume>: <fpage>3717</fpage>&#x02013;<lpage>3729</lpage>.<pub-id pub-id-type="pmid">19275168</pub-id></mixed-citation></ref><ref id="pone.0054648-Mebs1"><label>50</label><mixed-citation publication-type="journal">
<name><surname>Mebs</surname><given-names>D</given-names></name>, <name><surname>Kordis</surname><given-names>D</given-names></name>, <name><surname>Kendel</surname><given-names>Y</given-names></name>, <name><surname>Kauferstein</surname><given-names>S</given-names></name> (<year>2011</year>) <article-title>The evolution of alphaD-conopeptides targeting neuronal nicotinic acetylcholine receptors</article-title>. <source>Acta Chim Slov</source>
<volume>58</volume>: <fpage>730</fpage>&#x02013;<lpage>734</lpage>.<pub-id pub-id-type="pmid">24061122</pub-id></mixed-citation></ref><ref id="pone.0054648-Buczek2"><label>51</label><mixed-citation publication-type="journal">
<name><surname>Buczek</surname><given-names>O</given-names></name>, <name><surname>Jimenez</surname><given-names>EC</given-names></name>, <name><surname>Yoshikami</surname><given-names>D</given-names></name>, <name><surname>Imperial</surname><given-names>JS</given-names></name>, <name><surname>Watkins</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>I(1)-superfamily conotoxins and prediction of single D-amino acid occurrence</article-title>. <source>Toxicon</source>
<volume>51</volume>: <fpage>218</fpage>&#x02013;<lpage>229</lpage>.<pub-id pub-id-type="pmid">17996262</pub-id></mixed-citation></ref><ref id="pone.0054648-Fan1"><label>52</label><mixed-citation publication-type="journal">
<name><surname>Fan</surname><given-names>CX</given-names></name>, <name><surname>Chen</surname><given-names>XK</given-names></name>, <name><surname>Zhang</surname><given-names>C</given-names></name>, <name><surname>Wang</surname><given-names>LX</given-names></name>, <name><surname>Duan</surname><given-names>KL</given-names></name>, <etal>et al</etal> (<year>2003</year>) <article-title>A novel conotoxin from <italic>Conus betulinus,</italic> kappa-BtX, unique in cysteine pattern and in function as a specific BK channel modulator</article-title>. <source>J Biol Chem</source>
<volume>278</volume>: <fpage>12624</fpage>&#x02013;<lpage>12633</lpage>.<pub-id pub-id-type="pmid">12547831</pub-id></mixed-citation></ref><ref id="pone.0054648-Yuan1"><label>53</label><mixed-citation publication-type="journal">
<name><surname>Yuan</surname><given-names>DD</given-names></name>, <name><surname>Liu</surname><given-names>L</given-names></name>, <name><surname>Shao</surname><given-names>XX</given-names></name>, <name><surname>Peng</surname><given-names>C</given-names></name>, <name><surname>Chi</surname><given-names>CW</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>New conotoxins define the novel I3-superfamily</article-title>. <source>Peptides</source>
<volume>30</volume>: <fpage>861</fpage>&#x02013;<lpage>865</lpage>.<pub-id pub-id-type="pmid">19428762</pub-id></mixed-citation></ref><ref id="pone.0054648-Biggs1"><label>54</label><mixed-citation publication-type="journal">
<name><surname>Biggs</surname><given-names>JS</given-names></name>, <name><surname>Watkins</surname><given-names>M</given-names></name>, <name><surname>Puillandre</surname><given-names>N</given-names></name>, <name><surname>Ownby</surname><given-names>JP</given-names></name>, <name><surname>Lopez-Vera</surname><given-names>E</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Evolution of Conus peptide toxins: analysis of Conus californicus Reeve, 1844</article-title>. <source>Mol Phylogenet Evol</source>
<volume>56</volume>: <fpage>1</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="pmid">20363338</pub-id></mixed-citation></ref><ref id="pone.0054648-Lluisma1"><label>55</label><mixed-citation publication-type="journal">
<name><surname>Lluisma</surname><given-names>AO</given-names></name>, <name><surname>Lopez-Vera</surname><given-names>E</given-names></name>, <name><surname>Bulaj</surname><given-names>G</given-names></name>, <name><surname>Watkins</surname><given-names>M</given-names></name>, <name><surname>Olivera</surname><given-names>BM</given-names></name> (<year>2008</year>) <article-title>Characterization of a novel psi-conotoxin from Conus parius Reeve</article-title>. <source>Toxicon</source>
<volume>51</volume>: <fpage>174</fpage>&#x02013;<lpage>180</lpage>.<pub-id pub-id-type="pmid">18054976</pub-id></mixed-citation></ref><ref id="pone.0054648-Lu1"><label>56</label><mixed-citation publication-type="journal">
<name><surname>Lu</surname><given-names>BS</given-names></name>, <name><surname>Yu</surname><given-names>F</given-names></name>, <name><surname>Zhao</surname><given-names>D</given-names></name>, <name><surname>Huang</surname><given-names>PT</given-names></name>, <name><surname>Huang</surname><given-names>CF</given-names></name> (<year>1999</year>) <article-title>Conopeptides from Conus striatus and Conus textile by cDNA cloning</article-title>. <source>Peptides</source>
<volume>20</volume>: <fpage>1139</fpage>&#x02013;<lpage>1144</lpage>.<pub-id pub-id-type="pmid">10573284</pub-id></mixed-citation></ref><ref id="pone.0054648-Lirazan1"><label>57</label><mixed-citation publication-type="journal">
<name><surname>Lirazan</surname><given-names>MB</given-names></name>, <name><surname>Hooper</surname><given-names>D</given-names></name>, <name><surname>Corpuz</surname><given-names>GP</given-names></name>, <name><surname>Ramilo</surname><given-names>CA</given-names></name>, <name><surname>Bandyopadhyay</surname><given-names>P</given-names></name>, <etal>et al</etal> (<year>2000</year>) <article-title>The spasmodic peptide defines a new conotoxin superfamily</article-title>. <source>Biochemistry</source>
<volume>39</volume>: <fpage>1583</fpage>&#x02013;<lpage>1588</lpage>.<pub-id pub-id-type="pmid">10677206</pub-id></mixed-citation></ref><ref id="pone.0054648-England1"><label>58</label><mixed-citation publication-type="journal">
<name><surname>England</surname><given-names>LJ</given-names></name>, <name><surname>Imperial</surname><given-names>J</given-names></name>, <name><surname>Jacobsen</surname><given-names>R</given-names></name>, <name><surname>Craig</surname><given-names>AG</given-names></name>, <name><surname>Gulyas</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>1998</year>) <article-title>Inactivation of a serotonin-gated ion channel by a polypeptide toxin from marine snails</article-title>. <source>Science</source>
<volume>281</volume>: <fpage>575</fpage>&#x02013;<lpage>578</lpage>.<pub-id pub-id-type="pmid">9677203</pub-id></mixed-citation></ref><ref id="pone.0054648-Jakubowski1"><label>59</label><mixed-citation publication-type="journal">
<name><surname>Jakubowski</surname><given-names>JA</given-names></name>, <name><surname>Keays</surname><given-names>DA</given-names></name>, <name><surname>Kelley</surname><given-names>WP</given-names></name>, <name><surname>Sandall</surname><given-names>DW</given-names></name>, <name><surname>Bingham</surname><given-names>JP</given-names></name>, <etal>et al</etal> (<year>2004</year>) <article-title>Determining sequences and post-translational modifications of novel conotoxins in <italic>Conus victoriae</italic> using cDNA sequencing and mass spectrometry</article-title>. <source>J Mass Spectrom</source>
<volume>39</volume>: <fpage>548</fpage>&#x02013;<lpage>557</lpage>.<pub-id pub-id-type="pmid">15170751</pub-id></mixed-citation></ref><ref id="pone.0054648-Peng1"><label>60</label><mixed-citation publication-type="journal">
<name><surname>Peng</surname><given-names>C</given-names></name>, <name><surname>Liu</surname><given-names>L</given-names></name>, <name><surname>Shao</surname><given-names>X</given-names></name>, <name><surname>Chi</surname><given-names>C</given-names></name>, <name><surname>Wang</surname><given-names>C</given-names></name> (<year>2008</year>) <article-title>Identification of a novel class of conotoxins defined as V-conotoxins with a unique cysteine pattern and signal peptide sequence</article-title>. <source>Peptides</source>
<volume>29</volume>: <fpage>985</fpage>&#x02013;<lpage>991</lpage>.<pub-id pub-id-type="pmid">18304695</pub-id></mixed-citation></ref><ref id="pone.0054648-Yuan2"><label>61</label><mixed-citation publication-type="journal">
<name><surname>Yuan</surname><given-names>DD</given-names></name>, <name><surname>Liu</surname><given-names>L</given-names></name>, <name><surname>Shao</surname><given-names>XX</given-names></name>, <name><surname>Peng</surname><given-names>C</given-names></name>, <name><surname>Chi</surname><given-names>CW</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Isolation and cloning of a conotoxin with a novel cysteine pattern from Conus caracteristicus</article-title>. <source>Peptides</source>
<volume>29</volume>: <fpage>1521</fpage>&#x02013;<lpage>1525</lpage>.<pub-id pub-id-type="pmid">18584917</pub-id></mixed-citation></ref><ref id="pone.0054648-Luo3"><label>62</label><mixed-citation publication-type="journal">
<name><surname>Luo</surname><given-names>SQ</given-names></name>, <name><surname>Kulak</surname><given-names>JM</given-names></name>, <name><surname>Cartier</surname><given-names>GE</given-names></name>, <name><surname>Jacobsen</surname><given-names>RB</given-names></name>, <name><surname>Yoshikami</surname><given-names>D</given-names></name>, <etal>et al</etal> (<year>1998</year>) <article-title>alpha-Conotoxin AuIB selectively blocks alpha 3 beta 4 nicotinic acetylcholine receptors and nicotine-evoked norepinephrine release</article-title>. <source>Journal of Neuroscience</source>
<volume>18</volume>: <fpage>8571</fpage>&#x02013;<lpage>8579</lpage>.<pub-id pub-id-type="pmid">9786965</pub-id></mixed-citation></ref><ref id="pone.0054648-Teichert1"><label>63</label><mixed-citation publication-type="journal">
<name><surname>Teichert</surname><given-names>RW</given-names></name>, <name><surname>Rivier</surname><given-names>J</given-names></name>, <name><surname>Torres</surname><given-names>J</given-names></name>, <name><surname>Dykert</surname><given-names>J</given-names></name>, <name><surname>Miller</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>A uniquely selective inhibitor of the mammalian fetal neuromuscular nicotinic acetylcholine receptor</article-title>. <source>J Neurosci</source>
<volume>25</volume>: <fpage>732</fpage>&#x02013;<lpage>736</lpage>.<pub-id pub-id-type="pmid">15659611</pub-id></mixed-citation></ref><ref id="pone.0054648-Jimenez1"><label>64</label><mixed-citation publication-type="journal">
<name><surname>Jimenez</surname><given-names>EC</given-names></name>, <name><surname>Olivera</surname><given-names>BM</given-names></name>, <name><surname>Teichert</surname><given-names>RW</given-names></name> (<year>2007</year>) <article-title>AlphaC-conotoxin PrXA: a new family of nicotinic acetylcholine receptor antagonists</article-title>. <source>Biochemistry</source>
<volume>46</volume>: <fpage>8717</fpage>&#x02013;<lpage>8724</lpage>.<pub-id pub-id-type="pmid">17608455</pub-id></mixed-citation></ref><ref id="pone.0054648-Loughnan2"><label>65</label><mixed-citation publication-type="journal">
<name><surname>Loughnan</surname><given-names>M</given-names></name>, <name><surname>Nicke</surname><given-names>A</given-names></name>, <name><surname>Jones</surname><given-names>A</given-names></name>, <name><surname>Schroeder</surname><given-names>CI</given-names></name>, <name><surname>Nevin</surname><given-names>ST</given-names></name>, <etal>et al</etal> (<year>2006</year>) <article-title>Identification of a novel class of nicotinic receptor antagonists: dimeric conotoxins VxXIIA, VxXIIB, and VxXIIC from <italic>Conus vexillum</italic>
</article-title>. <source>J Biol Chem</source>
<volume>281</volume>: <fpage>24745</fpage>&#x02013;<lpage>24755</lpage>.<pub-id pub-id-type="pmid">16790424</pub-id></mixed-citation></ref><ref id="pone.0054648-Kauferstein1"><label>66</label><mixed-citation publication-type="journal">
<name><surname>Kauferstein</surname><given-names>S</given-names></name>, <name><surname>Kendel</surname><given-names>Y</given-names></name>, <name><surname>Nicke</surname><given-names>A</given-names></name>, <name><surname>Coronas</surname><given-names>FI</given-names></name>, <name><surname>Possani</surname><given-names>LD</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>New conopeptides of the D-superfamily selectively inhibiting neuronal nicotinic acetylcholine receptors</article-title>. <source>Toxicon</source>
<volume>54</volume>: <fpage>295</fpage>&#x02013;<lpage>301</lpage>.<pub-id pub-id-type="pmid">19393680</pub-id></mixed-citation></ref><ref id="pone.0054648-Teichert2"><label>67</label><mixed-citation publication-type="journal">
<name><surname>Teichert</surname><given-names>RW</given-names></name>, <name><surname>Jimenez</surname><given-names>EC</given-names></name>, <name><surname>Olivera</surname><given-names>BM</given-names></name> (<year>2005</year>) <article-title>Alpha S-conotoxin RVIIIA: a structurally unique conotoxin that broadly targets nicotinic acetylcholine receptors</article-title>. <source>Biochemistry</source>
<volume>44</volume>: <fpage>7897</fpage>&#x02013;<lpage>7902</lpage>.<pub-id pub-id-type="pmid">15910004</pub-id></mixed-citation></ref><ref id="pone.0054648-Shon1"><label>68</label><mixed-citation publication-type="journal">
<name><surname>Shon</surname><given-names>KJ</given-names></name>, <name><surname>Grilley</surname><given-names>M</given-names></name>, <name><surname>Jacobsen</surname><given-names>R</given-names></name>, <name><surname>Cartier</surname><given-names>GE</given-names></name>, <name><surname>Hopkins</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>1997</year>) <article-title>A noncompetitive peptide inhibitor of the nicotinic acetylcholine receptor from <italic>Conus purpurascens</italic> venom</article-title>. <source>Biochemistry</source>
<volume>36</volume>: <fpage>9581</fpage>&#x02013;<lpage>9587</lpage>.<pub-id pub-id-type="pmid">9236004</pub-id></mixed-citation></ref></ref-list></back></article>